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  i 
Abstract 
This thesis outlines the synthesis and characterization of the first alkynyl-substituted 
boron formazanate complexes and explores the electronic and structural changes that 
occur in these systems as a result of chemical modification at the boron centre. An 
alkynyl-substituted complex appended with a redox-active handle is also described, and 
the chemical reduction and oxidation of this system is explored. Finally, a model 
reaction is examined as a proof of concept toward the post-synthetic modification of 
these boron formazanate systems through copper(I)-assisted alkyne-azide 
cycloaddition chemistry. Exploiting chemistry at the boron centre opens up new 
possibilities toward incorporating function onto the boron formazanate scaffold. 
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  ii 
Co-Authorship Statement 
 
The work described in this thesis contains contributions from the author as well as Ryan 
Maar and Profs. Mark S. Workentin and Joe B. Gilroy. The contributions of each are 
described below. 
 
Chapter 1 was written by the author and edited by Profs. Mark S. Workentin and Joe B. 
Gilroy. 
 
Chapter 2 describes the synthesis of a family of alkynyl-substituted boron formazanate 
complexes that were completed by the author. All X-ray crystallographic data described 
was collected and refined by Ryan Maar. The chapter was written by the author and 
edited by Profs. Mark S. Workentin and Joe B. Gilroy. 
 
Chapter 3 describes post-synthetic modification of alkynyl-substituted complexes, and 
a redox-active complex and its radical derivatives that were completed by the author. 
All X-ray crystallographic data described was collected and refined by Ryan Maar. The 
chapter was written by the author and edited by Prof. Mark S. Workentin and Prof. Joe 
B. Gilroy. 
 
Chapter 4 was written by the author and edited by Profs. Mark S. Workentin and Joe B. 
Gilroy. 
 
 
 
 
 
 
 
  iii 
Acknowledgements 
 
First and foremost, I would like to thank both Prof. Joe Gilroy and Prof. Mark 
Workentin for their incredible mentorship and support over the past two years. I learned 
an incredible amount from you both and truly appreciate the time you spent helping me 
to become a better presenter, writer and chemist. Your enthusiasm, patience and 
dedication made this an incredibly enjoyable experience. Thank you both for giving me 
the opportunity to work as a member of your groups. 
 
Secondly I would like to thank all the past and present graduate students in both the 
Gilroy and Workentin groups. From the Gilroy group, I want to thank Ryan for his time, 
knowledge and patience showing me the ropes and giving me advice when things didn’t 
go smoothly. Thanks to Jas and Daniela for the endless entertainment you two provide 
as you bicker like an old, married couple. Sam and Steph, thanks for always making it 
fun to come into lab, even when things weren’t going well. From the Workentin group, 
I want to thank Wilson, Praveen, Tommy, Vaish, Raj, Justin, Kyle and honorary 
member Jeff for always keeping me entertained and having a good time over coffee and 
cards. I can safely say I wouldn’t have made it through grad school without you all. I 
would also like to thank the rest of the graduate students I had the pleasure of working 
and spending time with, especially our ultimate Frisbee teams. 
 
I want to express my gratitude to the entire faculty of Chemistry, whom over the course 
of my undergraduate and graduate studies I’ve had the pleasure of learning from. Thank 
you to the support staff – Mat Willans, Doug Hairsine, Yves Rambour, Aneta Borecki, 
Paul Boyle, Monica Chirigel, Marylou Hart and Darlene McDonald for always being 
there and willing to help me. 
 
Thank you to my committee – Prof. Mike Kerr, Prof. François Lagugné-Labarthet and 
Prof. Ilka Heinemann for taking the time to read my thesis. 
  iv 
Finally, I want to thank my family. To my parents, I want to thank you for your immense 
support over the years and all the sacrifices you’ve made to get me where I am today. 
I’m deeply grateful for your encouragement, advice and for always being there when I 
needed you. I could not have done this without you. To my siblings, thank you for 
providing me with endless entertainment. To my friends and family, thank you for the 
friendship and support throughout the years. I love you all. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  v 
Table of Contents 
Abstract ........................................................................................................................... i	
Keywords ........................................................................................................................ i	
Co-Authorship Statement ............................................................................................... ii	
Acknowledgements ....................................................................................................... iii	
Table of Contents ........................................................................................................... v	
List of Tables ............................................................................................................... vii	
List of Figures ............................................................................................................. viii	
List of Schemes .............................................................................................................. x	
List of Appendices ....................................................................................................... xii	
List of Abbreviations .................................................................................................. xiii	
Chapter 1 ........................................................................................................................ 1	
1.1	 Introduction ......................................................................................................... 1	
1.2	 Boron complexes of b-diketiminates .................................................................. 1	
1.3	 Boron Complexes of Anilido-imines & Anilido-pyridines ................................ 3	
1.4	 Boron dipyrromethenes (BODIPYs) ................................................................... 7	
1.5	 BODIPY Derivatization via Fluorine Displacement ........................................ 11	
1.5.1	O-BODIPY .................................................................................................. 12	
1.5.2	E-BODIPY ................................................................................................... 14	
1.6	 Formazans & BF2 Formazanate Complexes ..................................................... 17	
1.7	 Scope of Thesis ................................................................................................. 22	
1.8	 References ......................................................................................................... 23	
Chapter 2 ...................................................................................................................... 26	
2.1 Introduction ............................................................................................................ 26	
2.2 Results & Discussion ............................................................................................. 28	
2.2.1 Synthesis of Alkynyl-Substituted Boron Formazanate Complexes ............ 28	
2.2.2 X-Ray Crystallography ................................................................................ 33	
2.2.3 UV-Visible Absorption Spectroscopy ......................................................... 34	
2.2.4 Electrochemical Properties .......................................................................... 36	
2.3 Conclusions ............................................................................................................ 39	
2.4 Experimental .......................................................................................................... 40	
  vi 
2.4.1 General Considerations ............................................................................... 40	
2.4.2 X-ray Crystallography Methods .................................................................. 40	
2.4.3 Electrochemical Methods ............................................................................ 43	
2.4.4 Synthetic Procedures ................................................................................... 43	
2.5 References .............................................................................................................. 47	
Chapter 3 ...................................................................................................................... 49	
3.1 Introduction ............................................................................................................ 49	
3.2 Results & Discussion ............................................................................................. 51	
3.2.1 Synthesis of a Redox-Active Alkynyl-Substituted Boron Formazante 
Complex ............................................................................................................... 51	
3.2.2 X-ray Crystallography ................................................................................. 53	
3.2.3 Electrochemical Properties .......................................................................... 55	
3.2.4 Reduced & Oxidized Forms of Redox-Active Complex 3.5 ....................... 57	
3.2.5 UV-Visible Absorption Spectroscopy ......................................................... 59	
3.2.6 Post-synthetic Functionalization via Cu(I)-Catalyzed Click Chemistry ..... 63	
3.2.7 UV-Visible Absorption Spectroscopy ......................................................... 67	
3.3 Conclusions ............................................................................................................ 68	
3.4 Experimental .......................................................................................................... 70	
3.4.1 General Considerations ............................................................................... 70	
3.4.2 X-ray Crystallography Methods .................................................................. 71	
3.4.3 Electrochemical Methods ............................................................................ 72	
3.4.4 Electron Paramagnetic Resonance Spectroscopy ........................................ 73	
3.4.5 Synthetic Procedures ................................................................................... 73	
3.5 References .............................................................................................................. 78	
Chapter 4 ...................................................................................................................... 80	
4.1 Conclusions ............................................................................................................ 80	
4.2 Future Work ........................................................................................................... 84	
Appendices ................................................................................................................... 86	
Appendix A – Supporting Information for Chapter 2 .................................................. 86	
Appendix B – Supporting Information for Chapter 3 .................................................. 92	
Curriculum Vitae ......................................................................................................... 97	
 
  vii 
List of Tables 
Table 2.1. IR stretches for the internal alkyne of compounds 2.8–2.10. ..................... 32	
Table 2.2. Selected bond lengths (Å) and bond angles (°) of compounds 2.7 and 2.8.
...................................................................................................................................... 34	
Table 2.3. Spectroscopic properties of complexes 2.7–2.10. ...................................... 36	
Table 2.4. Summary of the electrochemical properties of compounds 2.7–2.10.a ...... 37	
Table 2.5. X-ray diffraction data collection and refinement details for compounds 2.7 
and 2.8. ......................................................................................................................... 42	
Table 3.1. Selected bond lengths (Å) and angles (°) of compounds 2.7, 2.8 and 
3.5.................................................................................................................................55 
Table 3.2. Summary of the electrochemical properties of compounds 2.7, 2.8 and 
3.5.a………………………………………………………………………………...…56 
Table 3.3. Spectroscopic properties of complexes 3.5, 3.6 and 3.8………………...…61 
Table 3.4. Spectroscopic properties of complexes 2.8 and 3.7……..…………………62 
Table 3.5. Spectroscopic properties of complexes 3.10 and 3.12……………………..68 
Table 3.6. X-ray diffraction data collection and refinement details for compound 
3.5………………………………………………………………………………….....72 
 
 
 
 
 
 
 
 
 
 
 
 
  viii 
List of Figures 
Figure 2.1. 1H NMR spectrum of compound 2.6 in CDCl3. ....................................... 30	
Figure 2.2. 1H NMR spectrum of compound 2.7 in CDCl3. ....................................... 30	
Figure 2.3. 19F (a) and 11B (b) NMR spectra of compound 2.7 recorded in CDCl3. ... 31	
Figure 2.4. IR spectra of compounds 2.8 (red), 2.9 (blue) and 2.10 (green). Black box 
indicates the internal alkyne stretch. ............................................................................ 32	
Figure 2.5. Top-view and side-view of the solid-state structures of a) 2.7 and b) 2.8. 
Thermal ellipsoids are shown at 50% probability and hydrogen atoms are removed for 
clarity. Substituents at the boron centre in the side-view of b) have been converted to 
wireframe for clarity. ................................................................................................... 34	
Figure 2.6. UV-Visible absorption spectra of compounds 2.7–2.10 recorded for 
degassed 10 µM toluene solutions. .............................................................................. 35	
Figure 2.7. Cyclic voltammograms of compounds 2.7 (black), 2.8 (red), 2.9 (blue) and 
2.10 (green) recorded in dry, degassed CH2Cl2 containing ~1 mM analyte and 0.1 M 
[nBu4N][PF6] as a supporting electrolyte at a scan rate of 250 mV s-1. Arrow indicates 
the direction of scan. .................................................................................................... 38	
Figure 3.1. IR Spectrum of complex 3.5. Arrow indicates the internal alkyne stretch at 
2188 cm–1.………………………………………………………………..…………...52 
Figure 3.2. Side-view solid state structures of a) 2.7, b) 2.8. Top-view and side-view 
solid-state structures of c) 3.5. Thermal ellipsoids are shown at 50% probability and 
hydrogen atoms are removed for clarity. Some substituents in b) and c) have been 
conferted to wireframe for clarity. a) and b) have been reproduced from Chapter 2 for 
comparison…………………………………………………………..……………….53 
Figure 3.3. Cyclic voltammograms of compounds 2.7 (blue), 2.8 (red), and 3.5 (green) 
recorded in dry, degassed CH2Cl2 containing ~1 mM analyte and 0.1 M [nBu4N][PF6] 
as a supporting electrolyte at a scan rate of 250 mV s-1. Arrows indicate the direction 
of scan…………………………………………………..…………………………….56 
Figure 3.4. UV-Visible absorption spectra of compounds 3.5, 3.6, and 3.8 recorded for 
degassed 10 µM CH3CN solutions………………………………………..…………..60 
  ix 
Figure 3.5. UV-Visible absorption spectra of compounds 2.8 and 3.7 recorded for 
degassed 10 µM CH3CN solutions……………………………………………………61 
Figure 3.6. EPR spectra of a) 3.6 and b) 3.7 in degassed THF at 298 K                                   
(g = 2.0035)…………………………………………………………………..……….62 
Figure 3.7. IR spectrum of compound 3.10. Arrows indicate the terminal acetylene 
functionality at 3281 and 2060 cm–1…………………………………………………..64 
Figure 3.8. 1H NMR spectra of compounds 3.9 (top), 3.10 (middle) and 3.12 (bottom) 
in CDCl3. Red highlights on structures indicate protons of interest.…………………..66 
Figure 3.9. IR spectra of compounds 3.10 (black), 3.11 (red) and 3.12 (blue)………..67 
Figure 3.10. UV-Visible absorption spectra of compounds 3.10 and 3.12 recorded for 
degassed 10 µM toluene solutions……………………………………………………68 
Figure 4.1. Formazanate and boron formazanate complexes studied in Chapter 2…...81 
Figure 4.2. Ferrocene complexes studied in Chapter 3……………………………….83 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  x 
List of Schemes 
Scheme 1.1. Synthesis of functional boron diiminate complexes. Yields are indicated 
in brackets.12 .................................................................................................................. 2	
Scheme 1.2. Synthesis of boron-containing anilido-imine complexes. Yields are 
indicated in brackets.17 ................................................................................................... 4	
Scheme 1.3. Suzuki-Miyaura coupling for the synthesis of boron-containing anilido-
pyridines.18 ..................................................................................................................... 5	
Scheme 1.4. Synthesis of boron-containing anilido-pyridines via Hartwig-Buchwald 
amination.18 .................................................................................................................... 6	
Scheme 1.5. Synthesis of alkyl-substituted BODIPY complexes.2 ............................... 9	
Scheme 1.6. Synthesis of a fluorescent pH-sensing BODIPY complex via Knoevenegal 
condensation.2 ................................................................................................................ 9	
Scheme 1.7. Synthesis of phenanthrene-fused BODIPY complexes. Yields indicated in 
brackets.23 ..................................................................................................................... 11	
Scheme 1.8. Synthesis of O-BODIPYs. Overall yields indicated in brackets.29 ......... 12	
Scheme 1.9. Synthesis of O-BODIPYs. Overall yields indicated in brackets.31 ......... 14	
Scheme 1.10. Synthesis of E-BODIPYs via lithiated terminal acetylenes.24 .............. 15	
Scheme 1.11. General synthesis of formazan ligands and resulting BF2 complexes.39
...................................................................................................................................... 18	
Scheme 1.12. Synthesis of 3-cyano BF2 formazanate complexes.38 ........................... 20	
Scheme 2.1. Synthesis of tri-p-tolyl BF2 formazanate complex 2.7. .......................... 29	
Scheme 2.2. Synthesis of alkynyl-substituted boron formazanate complexes 2.8–2.10.
...................................................................................................................................... 31	
Scheme 2.3. Stepwise electrochemical reduction of neutral boron-containing 
formazanate complexes (2.13) to the corresponding radical anion (2.12) and radical 
dianion (2.11) oxidation of neutral boron-containing formazanate complexes (2.13) to 
the corresponding radical cation (2.14). ...................................................................... 37	
Scheme 3.1. Synthesis of redox-active boron formazanate complex 3.5. Yield is 
indicated in brackets.………………………………………………………………....52 
  xi 
Scheme 3.2. Synthesis of the reduced ferrocene-containing boron formazanate complex 
3.6…………………………………………………………………………………….58 
Scheme 3.3. Synthesis of the reduced phenylacetylene complex 3.7…………………58 
Scheme 3.4. Synthesis of the oxidized ferrocene-containing boron formazanate 
complex 3.8…………………………………………………………………………..59 
Scheme 3.5. Synthesis of boron acetylene complex 3.10……………………………..63 
Scheme 3.6. CuAAC reaction with benzyl azide……………………………………..64 
Scheme 4.1. CuAAC chemistry studied in Chapter 3………………………………...84 
Scheme 4.2. Proposed Knoevenegal condensation and CuAAC toward the synthesis of 
multifunctional ethynyl-substituted boron formazanate complexes………………….85 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  xii 
List of Appendices 
Appendix A – Supporting Information for Chapter 2…………………………………86 
Appendix B – Supporting Information for Chapter 3…………………………………92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  xiii 
List of Abbreviations 
°  degree 
°C  degrees Celsius 
A  absorbance 
Å  angstrom 
a.u.  arbitrary units 
Ar  aryl 
ATR  attenuated total reflectance 
AlCl3  aluminum chloride 
BASi  Bioanalytical Systems Inc. 
BODIPY  boron dipyrromethene 
CCDC Cambridge crystallographic data centre 
CIEE  crystallization-induced emission ehnahcement 
cm–1  wavenumber 
CuAAC copper (I)-assisted alkyne-azide cycloaddition 
CV  cyclic voltammogram 
d  doublet 
DME  dimethoxyethane 
DMF  dimethylformamide 
dppf  bis(diphenylphosphino)ferrocene 
E°Fc  ferrocene oxidation potential 
EI  electron-impact ionization 
  xiv 
E°ox1  first oxidation potential 
EPR  electron paramagnetic resonance 
E°red1  first reduction potential 
E°red2  second reduction potential 
ESI  electrospray ionization 
Et  ethyl 
Et2O  diethyl ether 
EtOAc ethyl acetate 
EtOH  ethanol 
Fc  Ferrocene 
Fc+  Ferrocenium 
FT-IR  Fourier transform infra-red spectroscopy 
g  gram 
h  hour(s) 
Hz  hertz 
IR  infrared 
J  NMR coupling constant 
K  degrees Kelvin 
LDA  lithium diisopropylamide 
M  molar 
m  multiplet 
max  maximum 
  xv 
Me  methyl 
MeCN acetonitrile 
MeOH methanol 
mg  milligram 
MHz  megahertz 
min  minute/minutes 
mL  milliliter 
mM  millimolar 
mmol  millimoles 
mol  moles 
mV  millivolt 
n-BuLi n-butyllithium 
Na2CO3  sodium carbonate 
NaHCO3 sodium bicarbonate 
NEt3  triethyl amine 
nm  nanometer 
NMR  nuclear magnetic resonance 
OAc  acetate 
OMe  methoxy 
p  para 
Pd2(dba)3 tris(dibenzylideneacetone)dipalladium(0) 
Pd(PCy)3 bis(tricyclohexylphosphine)palladium(0) 
  xvi 
Pd(PPh3)4  tetrakis(triphenylphosphine)palladium(0) 
Ph  phenyl 
PMDETA N, N, N’, N’’, N’’-pentamethyldiethylenetriamine 
ppm  parts per million 
p-tol  para-tolyl 
π 	 	 pi 
ppm  parts per million 
ΦF   fluorescence quantum yield 
q  quartet 
TFA  trifluoroacetic acid 
r.t.  room temperature  
s  singlet 
t  triplet 
t-BuOK potassium tert-butoxide 
THF  tetrahydrofuran 
UV  ultraviolet 
UV-Vis ultraviolet-visible 
V  volts 
x  Cartesian axis 
XRD  X-ray diffraction 
y  Cartesian axis 
z  Cartesian axis 
  xvii 
α   crystallographic lattice constant, torsional angle 
β   crystallographic lattice constant, torsional angle 
γ   crystallographic lattice constant, torsional angle 
δ   chemical shift, partial charge 
ε   molar absorptivity 
θ   theta (range for crystallographic data collection) 
λ 	 	 wavelength 
λmax 	 	 wavelength of maximum absorption 
λem   wavelength of maximum emission 
  
  
1 
Chapter 1 
1.1 Introduction 
Over the past two decades, boron-containing complexes of chelating N-donor ligands 
have garnered significant interest as functional materials and have been extensively 
studied as a result of their unique properties, including high fluorescence quantum 
yields, high molar extinction coefficients, narrow absorption/emission bands and 
interesting redox chemistry.1 Their desirable properties have accelerated the use of 
these materials in a wide array of applications, including pH sensing,2,3 fluorescence 
imaging,4,5,6 biological labeling7,8 and photodynamic therapy.9 The incorporation of       
4-coordinate boron is a common occurrence throughout these examples, as it rigidifies 
the ligand systems, therefore reducing the non-radiative vibrational and rotational 
energy loss and increasing emission values. Numerous chelating N-donor ligands have 
been explored as the backbone of these boron-containing complexes, several of which 
are highlighted below.  
 
1.2 Boron complexes of b-diketiminates 
First discovered in the mid 1960s, b-diketiminates (1.1) were initially employed in the 
coordination chemistry of metal complexes.10 This monoanionic ligand is among the 
most fundamental chelating systems in coordination chemistry and has become more 
common throughout literature as a result of its facile synthesis including sterically 
demanding derivatives, and ease of tunability. As a result of its growing popularity, 
four-coordinate boron complexes of b-diketiminates have been synthesized in moderate 
yields (e.g. 1.2) and have been shown to have interesting luminescent properties.11  
                                                            
 
N
R2
N
R4
1.1
R5R1 N
R2
N
R4
1.2
B
FF
R1 R5
  
2 
For example, the Chujo group synthesized a series of functionalized boron-containing 
b-diketimines (1.6) and studied their use as light-emitting solid materials.12 The diimine 
ligands were synthesized via the reaction between N-phenylimine (1.3) and imidoyl 
chloride (1.4) with the corresponding substituents (Scheme 1.1). The BF2 moiety was 
then incorporated using BF3•OEt2 in toluene to afford a series of compounds (1.6a–d) 
with overall yields varying from 10 to 36%.  
 
 
Scheme 1.1. Synthesis of functional boron diiminate complexes. Yields are indicated 
in brackets.12 
 
The spectroscopic properties of compounds 1.6a–1.6d were studied, and it was found 
that all four compounds showed strong π→π* absorption transitions in the UV-Vis 
spectrum from λmax 355–391 nm. The emission of these compounds was found to be 
red-shifted with the introduction of electron donating substituents, with compounds 
1.6a–c emitting at 448, 473 and 470 nm, respectively, while compound 1.6d exhibited 
emission at 602 nm. All four compounds were weakly luminescent in THF at room 
temperature (298 K), with quantum yields of fluorescence (ΦF) below 0.01. Upon 
cooling to 77 K, the emission intensities of these compounds increased, indicating that 
the suppression of molecular vibrations and rotations plays an important role in their 
luminescence. Furthermore, it was discovered that upon crystallization, the emission 
drastically increased further, indicating these compounds are CIEE (crystallization-
induced emission enhancement) active. This process refers to a unique phenomenon in 
which a compound weakly emits as an amorphous solid, but emits more effectively in 
N
R4
R5
N
R1
R2
1) LDA, THF
2)
Cl
N HN
R4
R1
R2
R5
1.3
1.4
1.5
1.6a (20%): R1 = R2 = H, R4 = Me, R5 = H
1.6b (34%): R1 = R2 = H, R4 = Ph, R5 = H
1.6c (36%): R1 = OMe, R2 = H, R4 = Ph, R5 = H
1.6d (36%): R1 = H, R2 = NMe2, R4 = Ph, R5 = H
1) BF3   OEt2 N N
R4
B
FFR1
R2
R5
Toluene
1.6
  
3 
crystalline states. In the case of these compounds, both amorphous and crystalline 
samples were studied. Low intensity emission was observed from the amorphous 
samples (ΦF = 0.01–0.04) whereas the corresponding crystalline samples showed much 
more intense emission (ΦF = 0.04–0.59), indicating that these compounds are CIEE 
active.13,14  
 
1.3 Boron Complexes of Anilido-imines & Anilido-pyridines 
With a similar core structure to that of the b-diketiminates, boron complexes of anilido-
imines (e.g. 1.7) and anilido-pyridines (e.g. 1.8) have also been synthesized.15,16 These 
complexes exhibit large Stokes shifts and moderate quantum yields with tunable 
absorption and emission profiles.  
      
The Mu group synthesized a series of boron-containing anilido-imines and explored the 
effects of sterics on the absorption and emission of these complexes.17 The ligands were 
synthesized by stirring 2-fluorobenzaldehyde (1.9) in the presence of the corresponding 
aryl amine (1.10) to form 1.11, followed by the slow addition of a lithiated aryl amine 
at room temperature to afford 1.12 in 75–78% yield (Scheme 1.2). The anilido-imines 
were then lithiated at –78 oC in toluene using n-BuLi and stirred overnight at room 
temperature. The resulting mixture was added dropwise to a solution of BF3•OEt2 in 
toluene at –78 oC and stirred overnight at room temperature to afford compounds   
1.14a–c. The λmax values for compounds 1.14a, b and c were found to be 440, 440 and 
429 nm, with λem values of 511, 512, and 491 nm and ΦF values of 0.55, 0.57, and 0.58, 
respectively. It was found that by substituting hydrogen for methyl at the ortho position 
of the imine-bound phenyl ring forces a change in conformation such that the phenyl 
N N
1.7
B
FF
R1 R2 N N
B
FF
R1
1.8
  
4 
ring twists and decreases the extent of conjugation, thereby blue-shifting the absorption 
and emission maxima of 1.14c relative to 1.14a and 1.14b. 
 
Scheme 1.2. Synthesis of boron-containing anilido-imine complexes. Yields are 
indicated in brackets.17 
The λmax values of the boron-containing anilido-imine complexes were found to be 
significantly red-shifted (~80 nm) relative to the free anilido-imine ligands. These 
values suggested that the formation of the B-N bond lowers the π→π* energy gap, 
resulting in a red-shift of the absorption spectrum. Furthermore, the ΦF values of the 
boron-containing complexes were significantly higher than those of the free ligands  
(ΦF ~0.56 vs. ~0.03). The incorporation of the BF2 moiety also rigidifies the ring, 
therefore reducing the vibrational energy loss and increasing the ΦF values. 
 
Similar boron-containing complexes of anilido-pyridines were synthesized by the Piers 
group.18 The first series of complexes was prepared by Suzuki-Miyaura coupling of 2-
fluorophenylboronic acid (1.15) and the corresponding a-bromo pyridine in 
dimethoxyethane (DME) (Scheme 1.3). The resulting aryl fluoride (1.16) was then 
FO
H2N
R1
R1
R2
Hexanes, r.t.
FNR1
R2
R1
LiNHAr
THF, r.t.
HNNR1
R2
R1 R3
R3
n-BuLi
toluene,   78 oC
NNR1
R2
R1 R3
R3
Li
TolueneNNR
1
R2
R1 R3
R3
B
FF
1.9
1.10
1.11 1.12
1.131.14
1.14a (78%): R1 = H, R2 = Me, R3 = Et
1.14b (73%): R1 = H, R2 = Me, R3 = iPr
1.14c (71%): R1 = Me, R2 = H, R3 = iPr
BF3   OEt2
  78 oC
  
5 
treated with 2 equiv. of a lithiated aryl amine generated via n-BuLi in THF at –78 oC 
and the final solution was heated overnight. The ligand was then stirred in toluene with 
NEt3 and BF3•OEt2 and heated overnight to afford the final boron-containing anilido-
pyridines in 60% yield for the phenyl derivative and 84% for the diisopropylphenyl 
(dipp) derivative. 
 
 
Scheme 1.3. Suzuki-Miyaura coupling for the synthesis of boron-containing anilido-
pyridines.18 
The second series of complexes was synthesized through a palladium-catalyzed 
Hartwig-Buchwald amination of 10-bromobenzo[h]quinoline (1.19) and the respective 
aniline in toluene at 85 oC (Scheme 1.4). The resulting ligand was then stirred in toluene 
with NEt3 and BF3•OEt2 and heated overnight to afford the final boron-containing 
anilido-pyridines in an 81% yield for the phenyl derivative and 44% yield for the dipp 
derivative. 
 
B
OH
OH
F
N
Br
DME
Pd(PPh3)2Cl2
80 oC, 18 h
N F
2 LiN(H)Ar
Ar = Ph or
2,6-diisopropylphenyl
N HN ArTHF,  60 oC, 18 h
Toluene, 80 oC
NEt3
N N ArB
F F
1.15 1.16 1.17
1.18
BF3   OEt2
  
6 
 
Scheme 1.4. Synthesis of boron-containing anilido-pyridines via Hartwig-Buchwald 
amination.18 
The spectroscopic properties of these boron-containing anilido-pyridines was 
investigated. It was found that the less conjugated BF2 complexes (1.18) absorbed in 
the UV-Vis region in dichloromethane at λmax of 416 nm for the phenyl derivative and 
417 nm for the dipp derivative, with λem of 531 (ΦF = 0.33) and 511 nm (ΦF = 0.29), 
respectively. The more conjugated BF2 complexes (1.21) absorbed in the UV-Vis 
region at λmax of 465 nm for the phenyl derivative and 466 nm for the dipp derivative, 
with λem of 584 (ΦF = 0.60) and 569 nm (ΦF = 0.66), respectively. The large differences 
in fluorescence quantum yield could be explained when looking at the crystallographic 
data. X-ray crystallography of the Suzuki-coupled derivatives revealed significant 
twisting in the ligand backbone of complex 1.18, while the ligand backbone of the 
rigidified phenyl complex (1.21) was found to be completely flat. This led to the 
conclusion that the flexibility of the ligand backbone of complex 1.18 was providing 
nonradiative decay pathways for excited state relaxation, leading to decreased 
fluorescence quantum yields, while the rigidified phenyl complex 1.21 did not allow 
for the same nonradiative decay to occur. Furthermore, these complexes exhibited 
exceptional photostability when compared with current commercially available dyes, 
as their absorption profiles were unchanged after 10–16 h of irradiation at 420 nm in 
dichloromethane at room temperature. These properties have opened the possibility for 
these dyes to be used as fluorescent biological probes. 
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1.4 Boron dipyrromethenes (BODIPYs) 
Perhaps the most popular class of boron-containing dyes are known as boron 
dipyrromethenes (BODIPYs),1,19,20,21 which consist of a dipyrromethene core 
coordinated to a BF2 fragment (1.22). First synthesized in the late 1960s,22 these dyes 
have become incredibly popular as a result of their highly desirable properties, 
including high molar absorptivities and fluorescence quantum yields and narrow 
absorption/emission bands.  
 
Although popular, classical BODIPYs are difficult to synthesize and require numerous 
synthetic steps often employing expensive metal catalysts. These compounds are also 
generally hydrophobic and typically exhibit maximum wavelengths of emission (lem) 
below 550 nm, making their use in biological applications challenging. However, 
numerous groups have overcome these challenges by developing synthetic strategies 
and tuning the spectroscopic and solubility properties of these compounds via structural 
modification at the meso position (1.22 R8) as well as along the pyrrole rings                   
(1.22 R1–R3).  
 
For example, the Jiao group synthesized a series of isoindole BODIPY fluorophores 
(1.23–1.28), in which greater alkyl substitution was shown to red-shift their absorption 
and emission maxima and explored their use as near-IR emitting pH sensors.2 These 
compounds were synthesized via direct condensation of 3-chloroisoindolin-1-ylidene-
N,N-dimethylmethanamine (1.30) with the suitable derivatized pyrrole in order to 
produce the desired dipyrromethene core (Scheme 1.5). The BF2 moiety was then 
incorporated using BF3•OEt2 and NEt3 in toluene to afford the final BODIPY 
complexes in 20–50% yields.  
N B N
R7
R3 R5FF
R1
R2 R6
R8
1.22
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lmax/lem     570/599 nm    602/621 nm      605/629 nm 
 
 
lmax/lem     600/624 nm    609/631 nm      629/650 nm 
UV-Vis absorption spectra revealed increasingly red-shifted lmax and lem values with 
increasing alkyl substitution on the BODIPY core relative to the parent BODIPY (1.23), 
with all complexes exhibiting fluorescence quantum yields of 0.60–0.80. X-ray 
crystallography indicated the BODIPY cores were planar, with hydrogen bonding 
observed between the fluorine atoms and the pyrrolic proton, further rigidifying the 
structures. A gradual increase of the dihedral angle was observed between the free 
pyrrole and the BODIPY core with an increase of alkyl substitution at the free pyrrole 
(1.23–1.28), and as a result, a slight decrease in the fluorescence quantum yields was 
observed.   
 
N B N
FF
1.23
NH
N B N
FF
1.24
NH
N B N
FF
1.25
NH
N B N
FF
1.26
NH
N B N
FF
1.27
NH
N B N
FF
1.28
NH
  
9 
 
Scheme 1.5. Synthesis of alkyl-substituted BODIPY complexes.2 
 
Alkyl-substituted BODIPY derivative (1.28) was further functionalized with a 
dimethylaniline moiety via the Knoevenegal condensation of                                                         
4-(dimethylamino)benzaldehyde in the presence of piperidine in toluene to produce 
complex 1.33 in 75% yield (Scheme 1.6). It absorbed strongly at 713 nm and weak 
fluorescence in the near-IR at 805 nm (ΦF = 0.05), the latter due to intramolecular 
charge transfer. However, upon addition of trifluoroacetic acid (TFA), a stepwise 
disappearance of the absorption maxima (lmax) at 415 and 713 nm was observed, with 
the appearance of new blue-shifted bands centred at 354 and 671 nm. Furthermore, a 
blue shift in lem was seen from 805 to 702 nm along with an increase in fluorescence 
intensity, suggesting the formation of a monoprotonated species. This revealed 
promising potential for the BODIPY complex 1.32 as a ratiometric “turn-on” near-IR 
fluorescent pH sensor. 
 
Scheme 1.6. Synthesis of a fluorescent pH-sensing BODIPY complex via Knoevenegal 
condensation.2 
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Vicente and co-workers developed an efficient synthetic methodology for π-extended 
BODIPY systems in order to tune the absorption and emission maxima of their 
BODIPY systems to the red/near-IR region in order to target biological applications.23 
These phenanthrene-fused BODIPYs were synthesized by first reacting the initial 
halogenated BODIPYs (1.34) with 20 equivalents of 2-biphenylboronic acid in the 
presence of 5% Pd(PCy3) and 1 M Na2CO3(aq) in refluxing toluene for 5 h (Scheme 1.7). 
Bromination reactions were then carried out using 10 equiv. of Br2 and 10 equiv. of 
NaHCO3 in CH2Cl2. By then treating the resulting products (1.36) with 50 equiv. of 
K2CO3 and Pd(PPh3)4 in refluxing toluene for 2 h, the final phenanthrene-fused 
BODIPY complexes were synthesized in 61–70% yields (1.37). All three BODIPY 
derivatives exhibited a drastic red-shift in the UV-Vis absorption spectra, with lmax 
values from 566–590 for complexes 1.34a–c to 642–660 for complexes 1.37a–c, 
indicative of the increased π-conjugation. Emission wavelengths were also drastically 
red-shifted, with lem values from 597–640 to 671–701. Furthermore, it was found that 
upon slightly extending the conjugation at the meso position, 1.37c exhibited absorption 
and emission maxima further red-shifted relative to 1.37a and 1.37b. As a result, 1.37a 
was further studied for biological evaluation of cancerous human epithelial type 2 
(HEp2) cells. Due to its hydrophobic character, the complex was readily taken up by 
the cells and localized in the endoplasmic reticulum (ER). This compound showed no 
cytotoxicity toward the cells, and demonstrated strong emission in live cells. These 
results indicate that this synthetic methodology may be applied effectively as an 
affordable alternative toward employing near-IR BODIPY-based dyes as bioimaging 
agents. 
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Scheme 1.7. Synthesis of phenanthrene-fused BODIPY complexes. Yields indicated in 
brackets.23 
 
1.5 BODIPY Derivatization via Fluorine Displacement 
While BODIPYs are an incredibly popular class of fluorescent dyes, it has been shown 
that under irradiation in polar solvents, their photostability can be limited, which in turn 
limits their use in biological applications. The B-F bond has been identified as the main 
source of this instability.24 In an effort to remedy this instability, numerous groups have 
synthesized BODIPY derivatives where the fluorine atoms of the “F-BODIPY” are 
replaced with chloride,25 alkyl,26 aryl (“C-BODIPY”),27  alkoxy (“O-BODIPY)28,29,30,31 
or ethynyl (“E-BODIPY)24, 32,33,34,35 functionalities.  
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1.5.1 O-BODIPY 
The Hibert group synthesized a series of O-BODIPYs with alkoxy/aryloxy 
functionalities replacing the fluorine atoms at the boron centre.29 These compounds 
were synthesized via the direct condensation of a pyrrole (1.38) with 4-iodobenzoic 
acid in phosphorus oxychloride used as both a reagent and solvent at reflux for 1 h 
(Scheme 1.8). The corresponding dipyrromethene (1.39) was then stirred in a solution 
of toluene and NEt3 at 80 oC in the presence of BF3•OEt2 for 30 min to afford the F-
BODIPY (1.40) in a 19% yield. Treatment of the resulting BODIPY with AlCl3 in dry 
CH2Cl2 and subsequent addition of an alcohol resulted in poor to moderate conversion 
to the resulting O-BODIPY (1.41). Interestingly, the authors noted that the substitution 
of fluorine atoms did not occur in the absence of AlCl3, indicating this reagent plays an 
important role in activating the B-F bond such that subsequent nucleophilic substitution 
may occur. 
 
Scheme 1.8. Synthesis of O-BODIPYs. Overall yields indicated in brackets.29 
N
H
O
OH
I
POCl3 N HN
I
1.38 1.39
Toluene
NEt3 N B N
FF
I
1.40
1) AlCl3, CH2Cl2
2) ROH
N B N
ORRO
I
1.41
R = OMe (19%)
OEt (11%)
OiPr (7%)
OBn (10%)
OPh-4OMe (10%)
OPh-4Cl (12%)
OPh-4NO2 (10%)
OPh (4%)
BF3   OEt2
  
13 
The authors examined the spectroscopic properties of these O-BODIPYs and found that 
the introduction of various alcohols produced only minor changes in the absorption 
maxima (1–3 nm red shift), with the parent F-BODIPY exhibiting a lmax of 504 nm. 
Fluorescence quantum yields were calculated for all compounds, and it was found that 
relative to the parent F-BODIPY (ΦF = 0.57), only the iPr (ΦF = 0.67),                                 
OBn (ΦF = 0.65) and OPh-4NO2 (ΦF = 0.71) derivatives had higher quantum yields. Of 
these, only the OPh-4NO2 derivative was found to have a fluorescence lifetime longer 
than that of the parent F-BODIPY, and as a result this compound was explored further. 
Over the course of 12 h, it was found that this derivative had greater photostability than 
that of the parent BODIPY in aqueous media, supporting the notion of the B-F bond 
being the main source of instability in these complexes. Coupled with its greater 
fluorescence intensity, this O-BODIPY derivative shows promise as a label for cell-
based assays. 
 
The Chau group developed a one-pot pathway for the synthesis of O-BODIPYs in 
yields comparable to other methods in the literature.31 In this synthesis, the targeted 
BODIPY was synthesized directly from the corresponding aldehyde, pyrrole and 
trimethylborate (Scheme 1.9). Initially, 2,4-dimethylpyrrole (1.42) was reacted with the 
corresponding aldehyde in the presence of trifluoroacetic acid (TFA) in THF overnight 
(Scheme 1.9). The resulting dipyrromethane (1.43) was then oxidized using tetrachloro-
p-benzoquinone, followed by the addition of NEt3 and trimethyl borate, to afford the 
final O-BODIPYs after 24 h (1.45).  
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Scheme 1.9. Synthesis of O-BODIPYs. Overall yields indicated in brackets.31 
 
Derivatization at the meso position did not greatly affect the absorption and emission 
profiles of these compounds, as all compounds exhibited a lmax between 500 and 504 
nm and lem between 512 and 516 nm. Fluorescence quantum yields were determined 
for all compounds, and the 2-methylphenyl derivative exhibited a fluorescence quantum 
yield of ΦF = 0.93, approximately double that of the other compounds (ΦF = 0.32–0.48). 
This was attributed to the steric effect provided by the ortho methyl, which limits the 
ability of the phenyl ring to rotate, limiting the ability of the excited system to non-
radiatively decay through this mode of deactivation. 
 
1.5.2 E-BODIPY 
One of the biggest drawbacks of F- and O-BODIPY complexes is their inherently small 
Stokes shifts, which limits their use in advanced fluorescence techniques as a result of 
significant reabsorption. Typical BODIPY dyes used in biological labeling exhibit 
Stokes shifts of ~400 cm–1, meaning it is possible for the dyes to reabsorb emitted 
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photons, leading to undesired background signal and poor signal-to-noise ratio.36 To 
address this issue, efforts have been made to design fluorescent dyes with greater Stokes 
shifts. The Ziessel group developed a series of “cascade” systems incorporating E-
BODIPYs, in which two chromophores are present in one molecule and undergo a 
through-space energy transfer process.24 One chromophore behaves as the donor (high 
energy absorbing chromophore) while the other behaves as the acceptor (low energy 
emitting fluorophore). In order for this “cascade” system to be effective, there must be 
significant spectral overlap between the donor emission and acceptor absorption 
spectra. This design was a promising strategy to enhance the Stokes shifts of these 
compounds through the incorporation of chromophores at the boron centre using 
lithiated terminal acetylenes, giving rise to another class known as E-BODIPYs. In this 
synthesis, the desired terminal alkyne (1.46) was incorporated onto the BODIPY 
scaffold using a lithiation procedure in order to displace the B-F bond via a nucleophilic 
reaction (Scheme 1.10).  
 
 
Scheme 1.10. Synthesis of E-BODIPYs via lithiated terminal acetylenes.24 
 
A wide array of E-BODIPYs were synthesized (1.50–1.53) with moderate to good 
yields, and their spectroscopic properties were investigated. It was found that these 
newly synthesized compounds were very stable and stable in the presence of strong acid 
or base as well as polar solvents, unlike the parent F-BODIPY (1.48). This was 
attributed to the stabilization of the boron centre by the ethynyl donors. All compounds 
R 2.2 n-BuLi
THF,   78 oC
R
Li
N B N
1.46
R R
THF, r.t.
1.47
1.49
1.48
N B N
FF
  
16 
exhibited a strong π→π* absorption between 516–528 nm indicative of the BODIPY 
core, with a higher energy absorption at 284 (1.50), 371 (1.51), 323 (1.52) or                     
464 (1.53) nm relating to the respective polyaromatic functionalities bound to the boron 
atom through the acetylene moiety.  
 
 
 
For all the newly synthesized compounds, excitation in the 516–528 nm range led to 
strong emission in the 535–540 nm region with quantum yields of ΦF = 0.90–0.95. 
Interestingly, upon excitation of the more intense and higher energy absorption bands 
relating to the polyaromatic moieties, the observed emission was not from of the 
polyaromatic species but rather the BODIPY core. This resulted in nearly quantitative 
energy transfers (95–99%) with the exception of the naphthyl compound (1.50) due to 
poor spectral overlap with the BODIPY core. As a result, these E-BODIPYs exhibited 
a virtual Stokes shift of over 570–758 cm–1, making these dyes promising candidates 
for biological labeling experiments. 
 
 
N B N
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1.6 Formazans & BF2 Formazanate Complexes 
While much of the focus in the literature regarding BF2-based fluorescent dyes has 
focused on the BODIPY framework, formazanate ligands (1.54) that are derived from 
formazans (1.55) and their resulting BF2 complexes (1.56) have emerged as promising 
alternatives. Formazans are nitrogen-rich analogs of b-diketiminates that typically 
possess aryl substituents at the R1 and R5 positions, with R3 bearing alkyl, aryl, nitro or 
cyano functionalities. 
 
 
 
This new family of complexes has desirable spectroscopic and electrochemical 
properties that may be readily tuned via structural modification.37,38 For example, the 
Otten group synthesized a series of BF2 formazanate complexes and explored 
substituent effects on both optical and redox properties.39 Formazans were synthesized 
in a multi-step procedure where the hydrazones were first isolated after reacting the 
desired hydrazine (1.57) with an aryl aldehyde (1.58) in MeOH or EtOH (Scheme 1.11). 
Separately, a diazonium salt was prepared by mixing an aniline with water, HCl and 
NaNO2 at 0 oC. The diazonium salt was then added to a solution of the hydrazone in 
water, acetone and base at 0 oC. The solution was stirred overnight while warming to 
room temperature and the desired formazans (1.59) were isolated in various yields (11–
46%). The BF2 moiety was then incorporated using BF3•OEt2 and NEt3 in toluene at  
80 oC to afford the final complexes in 28–42% yield (1.61–1.67). 
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Scheme 1.11. General synthesis of formazan ligands and resulting BF2 complexes.39 
 
 
lmax/lem 517/641 nm       464/617 nm           502/586 nm               428/643 nm 
 
 
lmax/lem        482/640 nm              460/610 nm                           414/650 nm               
 
Compounds 1.61–1.67 were found to absorb strongly in the visible region of the         
UV-Vis spectrum (414–517 nm). In all cases, it was observed that upon replacing 
substituents for bulkier variants (phenyl for mesityl), a blue-shift in the absorption and 
emission spectra was observed. This was determined to be a result of a near 
perpendicular orientation of the mesityl group, as electrons are no longer conjugated 
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between the formazanate backbone and the mesityl ring. A blue-shift was also observed 
upon replacing phenyl or p-tolyl rings with more electronegative C6F5 rings, as a result 
of the more electronegative substituent increasing the HOMO/LUMO gap. All 
compounds with the exception of 1.63 (ΦF = 0.15) were found to be essentially non-
emissive (ΦF < 0.01). Redox properties of these complexes were also explored using 
cyclic voltammetry. It was found that all complexes exhibit two quasi-reversible 
reductions, corresponding to the formation of the radical anion and dianion and that 
redox potentials could be varied greatly by manipulating the substituents on the 
formazanate scaffold. Upon increasing the electron-donating ability of the R3 
substituent, redox potentials shifted to more negative values, while electron-
withdrawing substituents result in more positive potentials. Changing the nature of the 
N-aryl substituents to more electron-withdrawing substituents was found to push the 
redox potentials to more positive values, with the opposite trend holding true for 
electron-donating substituents. 
 
The Gilroy group has also explored BF2 formazanates and demonstrated their readily 
tunable optical and electronic properties through substituent modification.38,40,41 For 
example, a series of 3-cyano BF2 formazanates were synthesized in high yields (87–
91%) and their spectroscopic properties were explored. In air, cyanoacetic acid (1.68) 
was dissolved in water and NaOH (Scheme 1.12). Separately, the corresponding 
diazonium salt (1.69) was generated via the addition of a cold aqueous NaNO2 solution 
to mixture of water, HCl and the desired amine precursor. The diazonium was then 
slowly added to the basic cyanoacetic acid solution and stirred for 6 h, producing the 
desired formazan (1.70) in high yields (85–87%). The purified formazans were then 
stirred in a solution of BF3•OEt2, NEt3 and toluene at 80 oC overnight to produce the 
corresponding BF2 complexes. UV-Vis absorption spectroscopy data revealed that each 
of these complexes showed strong, substituent-dependent absorption from lmax 502 nm 
to 515 nm to 572 nm corresponding to the π→π* transition for complexes 1.71a–c, 
respectively. It was found that all three complexes were also emissive, with lem values 
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of 586 nm, 598 nm and 656 nm and ΦF values of 0.15, 0.14 and 0.77 for complexes 
1.71a–c, respectively. 
 
 
Scheme 1.12. Synthesis of 3-cyano BF2 formazanate complexes.38 
 
Substituent effects were also examined by cyclic voltammetry, where it was found that 
each complex exhibited two reversible reduction events, with the electron donating 
derivative (1.71c) exhibiting more negative reduction potentials and the electron 
withdrawing derivative (1.71b) exhibiting more positive reduction potentials relative to 
1.71a. Solid state structures revealed the boron atoms in all three complexes adopt a 
distorted tetrahedral geometry and are slightly displaced from the N4 plane of the 
formazanate backbone, while moderate twisting of the N-aryl substituents of all three 
complexes was also observed.  
 
Recently, the Gilroy group has also demonstrated the effect of extended p conjugation 
on the properties of BF2 formazanate dyes by systematically replacing phenyl with 
naphthyl substituents at the R1 and R5 positions of 3-CN, 3-NO2 and 3-phenyl BF2 
formazanates (1.72–1.78).41 
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lmax/lem 509/630 nm                530/656 nm                            551/682 nm                
ΦF            0.01            0.02              0.05 
 
lmax/lem                       491/584 nm                 558/669 nm   
ΦF                                            0.09           0.32     
 
 
lmax/lem                       488/587 nm                  563/677 nm   
ΦF                           0.03            0.28  
 
It was demonstrated that extending the p conjugation of these complexes red-shifted 
the absorption and emission maxima. However, compounds bearing a phenyl 
substituent at the 3 position were found to be non-emissive in solution, likely due to 
additional non-radiative decay pathways associated with the carbon-bound substituent. 
The Gilroy group confirmed this phenomenon in a recent publication in which 
protonation of a pyridine ring at the R3 position was found to significantly increase the 
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fluorescence intensity.42 X-ray crystallography revealed hydrogen bonding between the 
pyridyl NH and a p-toluenesulfonate counterion. This discovery supports the notion 
that upon protonation of the pyridine substituent at the 3-substituent, potential 
vibrational and rotational non-radiative decay pathways are restricted via steric 
hindrance and intermolecular hydrogen bonding. 
 
BODIPYs and BF2 formazanate dyes are both promising candidates for a wide array of 
applications as a result of their tunable spectroscopic properties. Where BF2 
formazanate dyes have the advantage is that they are more synthetically accessible 
(fewer steps) and can be isolated in greater yields. However, structural modification of 
BF2 formazanate complexes has been explored only at the 1, 3 and 5 positions of the 
formazanate backbone, while chemistry at the boron centre has not been explored to 
date.  
 
1.7 Scope of Thesis 
This thesis focuses on the synthesis of alkynyl-substituted boron formazanates, and 
explores the electronic and spectroscopic changes that result as various alkyne-based 
functionalities are introduced at boron, replacing the fluorine substituents of a BF2 
formazanate. The interest in this work lies in the possibility of developing new synthetic 
protocols to manipulate the boron formazanate scaffold, which may increase their 
overall stability, alter their properties and open the door for these molecules to be used 
in a broader scope of applications.  
 
Chapter 2 will focus on the synthesis and characterization of novel alkynyl-substituted 
boron formazanate complexes using an adapted methodology from BODIPY systems. 
A detailed comparison of their spectroscopic, electrochemical and X-ray 
crystallographic properties will be described. 
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Chapter 3 will focus on the post-synthetic modification and functionalization of 
alkynyl-substituted boron formazanate complexes, as well as a redox-active alkynyl-
substituted complex and its oxidized and reduced forms. A comparison of their 
spectroscopic and electrochemical properties will be described. X-ray crystallographic 
studies will also be discussed. 
 
Chapter 4 will summarize the impact of my work on the field and possible future 
directions for the project.  
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Chapter 2 
2.1 Introduction 
A significant amount of research has been done over the past two decades focusing on 
boron-containing complexes of chelating N-donor ligands.1,2 BODIPY systems in 
particular have garnered significant interest as functional materials and have been 
extensively studied as a result of their easily tunable optical and spectroscopic 
properties, making them promising candidates for a number of applications.3 The 
presence of the B-F bond, however, is an area of concern, as it results in some instability 
under irradiation and in polar solvents.4 Numerous BODIPY derivatives have been 
explored in which the fluorine atoms have been replaced in order to remedy this 
instability, giving rise to new families of BODIPYs including C-, O- and E-
BODIPYs.2,5 As previously mentioned, both O- and E-BODIPY derivatives exhibit an 
increased stability toward photoirradiation compared to their parent F-BODIPY 
counterparts, making them useful in biological labeling experiments, cell-based assays 
and solar cells. Ziessel et al. have extensively studied these E-BODIPY systems and 
developed novel bridged E-BODIPY dimers that were shown to have unique 
spectroscopic and redox properties (2.1–2.4).6  
     
N B N
H H
2.1
N B N
H
2.2
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Compounds 2.1–2.4 exhibited an intense π→π* absorption in the UV-Vis spectrum at 
roughly lmax = 515 nm corresponding to the BODIPY backbone, with dimers 2.3 and 
2.4 exhibiting transitions with extinction coefficients roughly double that of their 
monomeric counterparts. 2.1 and 2.3 exhibited very strong emission at 550 nm with ΦF 
values of 0.92–0.98. Irradiation of the pyrene moieties of 2.2 and 2.4 exhibited 
exclusive emission at 535 nm (ΦF = 0.80) corresponding to the BODIPY core, 
indicating a near quantitative energy transfer of 94%. These molecules also exhibited 
interesting redox properties, where in all cases, reversible oxidation and reduction 
processes could be observed at ~+0.9 and –1.4 V, respectively. It was found that by 
replacing the fluorine atoms with ethynyl moieties, oxidation potentials decreased by 
roughly 100 mV and reduction potentials shifted to more anodic potentials by roughly 
230 mV. Interestingly, the dimeric compound 2.4 was found to have an oxidative event 
involving two successive redox processes, indicating that the two anthracene 
substituents are electronically independent of one another.  
 
Another class of N-donor ligands that have been shown as potential BODIPY 
alternatives are BF2 formazanates (2.5). This family of compounds has been shown to 
exhibit readily tunable spectroscopic and electrochemical properties while being 
synthesized in high yields.7,8  
N B N
H
2.3
BN N
H
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Increasing electronic delocalization at the N-aryl substituents (R1 and R5) has been 
shown to red-shift the absorption and emission maxima of these compounds, while 
varying electron withdrawing and electron donating substituents at these positions has 
been shown to drastically affect the rich redox chemistry that these complexes exhibit. 
While much work has been done exploring the unique properties of BF2 formazanates, 
structural modification has not been explored at the boron centre. Chapter 2 presents 
the synthesis and characterization of the first reported alkynyl-substituted boron 
formazanate complexes using an adapted synthetic protocol previously reported for 
BODIPY-based systems. The spectroscopic, electrochemical and structural effects of 
these substitutions on the boron centre will be explored. 
 
2.2 Results & Discussion 
2.2.1 Synthesis of Alkynyl-Substituted Boron Formazanate 
Complexes  
Tri-p-tolylformazan (2.6) was synthesized according to a previously published 
procedure,9 and exhibited a characteristic NH shift in its 1H NMR spectrum at 15.42 
ppm (Figure 2.1). BF2 formazanate complex 2.7 was synthesized from the parent 
formazan 2.6 by heating at 80 oC in a toluene solution containing excess BF3•OEt2 and 
NEt3 for 14 h under inert atmosphere (Scheme 2.1). The resulting BF2 complex was 
synthesized in 86% yield.  
N
N N
N
R3
R5R1 B
F F
2.5
R1 = R5 = Aryl
R3 = CN, NO2, Aryl
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Scheme 2.1. Synthesis of tri-p-tolyl BF2 formazanate complex 2.7. 
 
The formation of compound 2.7 was accompanied by a colour change from red to deep 
purple (vide infra) and confirmed by 1H NMR spectroscopy including the loss of the 
diagnostic NH resonance (Figures 2.1 & 2.2). In addition, a 1:1:1:1 quartet in the 19F 
NMR spectrum (Figure 2.3a) is observed as a result of coupling to 11B with a spin of 3. 
Interestingly, a fraction of a septet can also be observed in the baseline of the 19F NMR 
spectrum (Figure 2.3a) with an intensity roughly 20% of the major 1:1:1:1 quartet. This 
is a result of coupling to the 10B isotope with a spin of 3/2, with the relative intensity 
resulting from a 20% isotopic abundance. Finally, a 1:2:1 triplet observed in the            
11B NMR spectrum (Figure 2.3b) as a result of coupling to two fluorine atoms also 
provides evidence for the incorporation of the BF2 functionality into the formazan.   
 
 
 
 
NH
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Figure 2.1. 1H NMR spectrum of compound 2.6 in CDCl3. 
 
 
 
Figure 2.2. 1H NMR spectrum of compound 2.7 in CDCl3. 
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Figure 2.3. 19F (a) and 11B (b) NMR spectra of compound 2.7 recorded in CDCl3. 
 
Upon isolating BF2 complex 2.7, a series of alkyne-substituted boron-containing 
formazanate complexes were synthesized by first dissolving 2.2 equiv. of the 
corresponding terminal acetylene in dry THF, cooling to -78 °C and stirring for 30 min 
(Scheme 2.2). 2.2 equiv. of n-BuLi was then added dropwise and the solution was 
stirred at -78 °C for 1 h, warmed to room temperature, and stirred for an additional 30 
min. Separately, a solution of 2.7 dissolved in dry THF was stirred for 15 min at room 
temperature. The lithiated terminal acetylene was then added dropwise to the solution 
of compound 2.7 in THF and the resulting solution was stirred for 2 h. 
 
 
Scheme 2.2. Synthesis of alkynyl-substituted boron formazanate complexes 2.8–2.10. 
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
3 2 1 0 -1 -2 -3
Chemical Shift (pp )
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 - 45.5 146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Che ical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
3 2 1 - - -
he ic l ift ( )
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (pp )
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
3 2 1 - - -
ic l ift ( )
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (pp )
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
3 2 0 -1 -2 -3
Che ical Shift (pp )
-0
.7
2
-0
.5
0
-0
.2
7
-14 .5 -145.0 -145.5 -146.0
Chemical Shift (p m)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 - 45.5 146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Che ical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
3 2 1 0 -1 -2 -3
Chemical Shift (ppm)
-0
.7
2
-0
.5
0
-0
.2
7
-144.5 -145.0 -145.5 -146.0
Chemical Shift (ppm)
-1
45
.1
6
-1
45
.0
8
-1
45
.0
4
-1
45
.0
1
-1
44
.9
7
-1
44
.9
3
-1
44
.8
9
a ba b
N
N N
N
B
F F
R Li
r.t., 2 h
N
N N
N
B
R R
THF
2.8 (35%): R = Phenyl
2.9 (17%): R = 4-methoxyphenyl
2.10 (17%): R = 4-trifluoromethylphenyl
2.7 2.8   2.10
2.2 equiv.
  
32 
The formation of complexes 2.8–2.10 was accompanied by colour changes from deep 
purple to red/orange for 2.8, red/brown for 2.9 and orange/brown for 2.10 upon the 
addition of the acetylene/n-BuLi solution to 2.7. The formation of 2.8 and 2.9 was 
accompanied by a disappearance of the 1:1:1:1 quartet in the corresponding 19F NMR 
spectrum as well as the disappearance of the 1:2:1 triplet and appearance of a broad 
singlet in the 11B NMR spectrum (Figures A1.2–1.7). The formation of 2.10 was 
accompanied by a disappearance of the 1:1:1:1 quartet and appearance of a singlet in 
the 19F NMR spectrum at -62.8 ppm attributed to the CF3 group, as well as the 
disappearance of the 1:2:1 triplet and appearance of a broad singlet in the 11B NMR 
spectrum (Figures A1.3, A1.6, A1.10). Further supporting the formation of these 
compounds was a diagnostic signal in each of their IR spectra indicating the presence 
of an internal alkyne functionality at roughly 2186 cm–1 (Figure 2.4, Table 2.1).  
 
Figure 2.4. IR spectra of compounds 2.8 (red), 2.9 (blue) and 2.10 (green). Black box 
indicates the internal alkyne stretch. 
 
 
 
Table 2.1. IR stretches for the internal alkyne of compounds 2.8–2.10. 
1950215023502550275029503150
Wavenumber (cm-1)
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Compound Wavenumber (cm–1) 
2.8 2186 
2.9 2189 
2.10 2188 
 
2.2.2 X-Ray Crystallography 
Single crystals for X-ray diffraction studies were grown by slow vapour diffusion of 
hexanes into a saturated THF solution (2.7) and hexanes into a saturated CH2Cl2 
solution (2.3) (Figure 2.7). The solid-state structures show that the boron atoms are 
four-coordinate and adopt a tetrahedral geometry. They also show a delocalized 
formazanate backbone with all C-N and N-N bond lengths between those of typical 
single and double bonds (Table 2.4).10 The C-N bond lengths for 2.7 and 2.8 fall 
between 1.3385(8) and 1.346(3) Å, while typical C-N single and double bonds are 1.47 
and 1.29 Å, respectively. The N-N bonds lengths for 2.7 and 2.8 fall between 1.3028(7) 
and 1.3136(3), while typical N-N single and double bonds are 1.45 and 1.25 Å, 
respectively. Complex 2.7 is relatively planar, with the boron atom displaced by          
0.094 Å relative to the formazanate backbone, while the boron atom of 2.8 is further 
displaced by 0.713 Å, as a result of much larger substituents bound to the boron centre. 
The 1,5-aryl substituents in complex 2.7 are slightly twisted with respect to the 
formazanate backbone, with the angle between the N1-N2-N3-N4 plane and the plane 
defined by the N-aryl substituents being 4.51 and 8.48°. Complex 2.8 exists in a 
‘dragonfly’ conformation where the dihedral angles between the 1,5-aryl substituents 
and formazanate backbone are significantly more twisted, with angles ranging from 
54.9 to 60.6°. The B-N bonds in complex 2.8 are slightly longer than those of complex 
2.7, with bond lengths of 1.560(9) and 1.566(1) Å for 2.7 and 1.573(3) and 1.575(4) Å 
for 2.8, indicating the boron atom of the parent BF2 complex is more strongly bound by 
the formazanate backbone.  
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Figure 2.5. Top-view and side-view of the solid-state structures of a) 2.7 and b) 2.8. 
Thermal ellipsoids are shown at 50% probability and hydrogen atoms are removed for 
clarity. Substituents at the boron centre in the side-view of b) have been converted to 
wireframe for clarity. 
 
Table 2.2. Selected bond lengths (Å) and bond angles (°) of compounds 2.7 and 2.8. 
 2.7 2.8 
B1-N1 1.566(1) 1.575(4) 
B1-N3 1.560(9) 1.573(3) 
N1-N2 1.3037(7) 1.312(3) 
N3-N4 1.3028(7) 1.316(3) 
C1-N2 1.3417(8) 1.346(3) 
C1-N4 1.3385(8) 1.344(3) 
Dihedral Anglesa 4.51, 8.48 54.92, 60.60 
Boron Displacementb 0.094 0.713 
aThe angle (°) between the N-aryl substituents and the N4 plane of the formazanate 
backbone. bDistance (Å) between B1 and the plane defined by the four N atoms. 
 
2.2.3 UV-Visible Absorption Spectroscopy 
The UV-Visible absorption spectra of compounds 2.7–2.10 are shown in Figure 2.5 and 
summarized in Table 2.2. Compounds 2.7–2.10 absorb in the visible region of the 
electromagnetic spectrum, however there is no substantial difference in the lmax values 
between compounds 2.8–2.10, although compounds 2.8–2.10 exhibit a slight blue-shift 
(11–13 nm) relative to the parent BF2 (2.7). The transitions may be assigned as p®p* 
transitions, as their energies and intensities closely match reported transitions of 
previously synthesized BF2 formazanate complexes.9,11  
a F1 F2 
B1 
N3 N1 
N2 N4 
C1 
b 
B1
11 N3 N1 
N2 N4 
C1 
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Figure 2.6. UV-Visible absorption spectra of compounds 2.7–2.10 recorded for 
degassed 10 µM toluene solutions. 
 
None of the compounds studied exhibited any detectable fluorescence, likely due to 
non-radiative vibrational and rotational decay pathways relating to the 3-phenyl 
substituent, which agrees with previous reports.7 Interestingly, a small solvatochromic 
effect (10–17 nm shift) is observed as the lmax values of the compounds blue-shift in 
more polar solvents, moving from toluene to CH3CN, indicating a degree of charge 
transfer. 
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Table 2.3. Spectroscopic properties of complexes 2.7–2.10.  
Compound Solvent lmaxa, nm, (e, M-1 cm–1) 
2.7 CH3CN 
THF 
CH2Cl2 
Toluene 
251 (20 350), 313 (22 700), 522 (21 500) 
265 (21 250), 315 (21 500), 529 (19 550) 
253 (22 450), 318 (27 925), 529 (27 350) 
317 (21 900), 532 (20 200) 
2.8 CH3CN 
THF 
CH2Cl2 
Toluene 
257 (22 900), 312 (20 950), 504 (10 750) 
260 (6650), 314 (30 100), 517 (16 600) 
260 (23 070), 316 (35 050), 517 (19 200) 
320 (25 700), 521 (12 000) 
2.9 CH3CN 
THF 
CH2Cl2 
Toluene 
263 (35 750), 313 (28 500), 504 (12 850) 
262 (39 950), 313 (28 400), 516 (14 200) 
265 (44 850), 516 (15 550) 
317 (23 400), 519 (12 500) 
2.10 CH3CN 
THF 
CH2Cl2 
Toluene 
263 (32 400), 312 (24 300), 506 (11 750) 
265 (33 150), 313 (25 100), 517 (12 500) 
265 (36 050), 519 (12 650) 
317 (24 900), 521 (13 700) 
aValues recorded for degassed 10 µM solutions. 
 
2.2.4 Electrochemical Properties 
The electrochemical properties of compounds 2.7–2.10 were explored using cyclic 
voltammetry and are summarized in Table 2.4. Experiments were performed in dry, 
degassed CH2Cl2 and the cyclic voltammograms are shown in Figure 2.6. Compounds 
2.7–2.10 exhibited two ligand-centred reversible (or quasi-reversible) one-electron 
reduction waves relative to the ferrocene/ferrocenium redox couple. In this experiment, 
the neutral complex (2.13) is first reduced to form the radical anion (2.12) at the first 
half wave reduction potential (E°red1), followed by a second reduction to form the 
dianion (2.11) at the second half wave reduction potential (E°pc) (Scheme 2.3). In all 
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cases, the second reduction wave was found to become more chemically reversible as 
the scan rate increased. Compounds 2.7, 2.8 and 2.10 also exhibited one ligand-centred 
reversible (or quasi-reversible) one-electron oxidation wave relative to the 
ferrocene/ferrocenium redox couple, while 2.9 exhibited an irreversible oxidation 
event. In this experiment, the neutral complex (2.13) is oxidized to form the radical 
cation (2.14) at the half wave oxidation potential (E°ox1) (Scheme 2.3).  
 
 
 
Scheme 2.3. Stepwise electrochemical reduction of neutral boron-containing 
formazanate complexes (2.13) to the corresponding radical anion (2.12) and radical 
dianion (2.11) oxidation of neutral boron-containing formazanate complexes (2.13) to 
the corresponding radical cation (2.14).  
 
 
Table 2.4. Summary of the electrochemical properties of compounds 2.7–2.10.a 
Compound E°red1 (V) E°red2 (V)b E°ox1 (V) 
2.7 -1.04 -1.99 1.03 
2.8 -1.18 -2.03 0.83 
2.9 -1.21 -2.12 0.86c 
2.10	 -1.14	 -2.01	 0.89	
aCyclic voltammograms were recorded in dry, degassed CH2Cl2 containing ~1 mM 
analyte and 0.1 M [nBu4N][PF6] as a supporting electrolyte at a scan rate of                        
250 mV s-1. Cyclic voltammograms of compounds 2.7–2.10 were referenced internally 
against the ferrocene/ferrocenium redox couple. bReduction peaks are not reversible 
and the values listed are of the maximum cathodic current. cOxidation peak is not 
reversible, and the value listed is of the maximum anodic current.  
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Relative to the parent BF2 (2.7), compounds 2.8–2.10 were found to be more difficult 
to reduce and easier to oxidize with no fluorine atoms present. A trend may be observed 
when comparing compounds 2.8–2.10, as the data suggests 2.10 is the easiest to reduce 
(E°red1 = -1.14, E°pc = -2.03), followed by 2.8 (E°red1 = -1.18, E°pc = -2.01), with 
compound 2.9 being the most difficult to reduce (E°red1 = -1.21, E°pc = -2.12) (Table 
4). These results may be rationalized by considering the substituents bound to the 
phenylacetylene moiety. Compound 2.10 contains an electron withdrawing CF3 
substituent at the para position, making it slightly easier to reduce relative to compound 
2.9 bearing the electron donating OMe substituent at the para position, while compound 
2.8 lies between as it contains a hydrogen atom at the para position. 
 
 
 
Figure 2.7. Cyclic voltammograms of compounds 2.7 (black), 2.8 (red), 2.9 (blue) and 
2.10 (green) recorded in dry, degassed CH2Cl2 containing ~1 mM analyte and 0.1 M 
[nBu4N][PF6] as a supporting electrolyte at a scan rate of 250 mV s-1. Arrow indicates 
the direction of scan. 
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2.3 Conclusions  
The first reported alkynyl-substitued boron formazanate complexes 2.8–2.10 were 
synthesized using a series of lithiated terminal acetylenes. X-ray crystallography 
indicated that upon replacing the fluorine atoms at the boron centre, B-N bonds were 
elongated and all C-N and N-N bond lengths were found to be between those of typical 
single and double bonds, indicating a significant degree of electronic delocalization. 
Significant twisting of the N-aryl substituents on the formazanate backbone was 
observed as a result of the increased steric bulk at the boron centre, with complex 2.8 
existing in a ‘dragonfly’ conformation where the dihedral angles between the 1,5-aryl 
substituents and formazanate backbone ranged from 54.9 to 67.9°. IR spectra confirmed 
the presence of an alkyne functionality at 2186-2189 cm-1 for compounds 2.8–2.10. 
Compounds 2.8–2.10 were found to absorb within the visible region of the 
electromagnetic spectrum and were also found to be non-emissive. Compounds 2.8–
2.10 exhibited a slight blue-shift in the UV-Visible spectrum relative to the parent BF2 
complex 2.7 and a small solvatochromic effect (10–17 nm shift) moving from toluene 
to CH3CN. Cyclic voltammetry demonstrated that complexes 2.8–2.10 were redox 
active and exhibited two quasi-reversible one-electron reduction processes and one 
quasi-reversible oxidation process relative to the ferrocene/ferrocenium redox couple. 
Electrochemical data also suggested compound 2.10 was the easiest to reduce as a result 
of the electron withdrawing CF3 at the para position of the phenyl substituent while 
compound 2.9 was the most difficult to reduce as a result of the electron donating OMe 
at the para position of the phenyl substituent.  
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2.4 Experimental 
2.4.1 General Considerations 
Solvents were obtained from Caledon Laboratories, dried using an Innovative 
Technologies Inc. solvent purification system, collected under vacuum, and stored 
under an N2 atmosphere over 4 Å molecular sieves. All other reagents were purchased 
from Sigma Aldrich, Alfa Aesar or TCI America and used as received. Formazan 2.6 
was synthesized according to a published procedure.9 NMR spectra were recorded on a 
Bruker 400 MHz NMR spectrometer, 400 MHz Varian INova NMR spectrometer, or 
600 MHz Varian Inova NMR spectrometer. 1H NMR spectra were recorded in CDCl3 
and referenced against residual protonated solvent at 7.27 ppm. 13C{1H} NMR spectra 
were referenced to CDCl3 at 77.0 ppm. 
11B NMR spectra were referenced internally to 
BF3•OEt2 at 0 ppm. 19F NMR spectra were referenced internally to CFCl3 at 0 ppm. 
Mass spectra were recorded in positive-ion mode using a high-resolution Finnigan 
MAT 8200 spectrometer. UV-Vis absorption spectra were recorded using a Cary 5000 
Scan instrument using standard quartz cells (1 cm path length) with a scan range of 200 
to 800 nm. Samples were dissolved in spectroscopic grade solvents to obtain various 
concentrations. The background was subtracted from each spectrum and the solvent 
used for each experiment is indicated. Emission spectra were recorded using a Photon 
Technology Internation QM–4 SE spectrofluorometer. FT-IR spectra were recorded 
using a Perkin Elmer Spectrum Two FT-IR spectrometer.  
 
2.4.2 X-ray Crystallography Methods 
Single crystals suitable for X-ray diffraction studies were grown by slow vapour 
diffusion of hexanes into a saturated THF solution (2.7) and hexanes into a saturated 
solution of CH2Cl2 (2.8) and were analyzed by Ryan Maar. Samples were mounted on 
a MiTeGen polyimide micromount with a small amount of Paratone N oil. X-ray 
measurements were made on a Bruker Kappa Axis Apex2 diffractometer or Nonius 
KappaCCD Apex2 diffractometer at a temperature of 110 K. The unit cell dimensions 
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of 2.7 were determined from a symmetry constrained fit of 9632 reflections with 5.06° 
< 2q < 75.3°. The data collection strategy was a number of ω and φ scans which 
collected data up to 84.298° (2q). The frame integration for both compounds was 
performed using SAINT.12 The resulting raw data was scaled and absorption corrected 
using a multi-scan averaging of symmetry equivalent data using SADABS.13 The 
structures were solved by using a dual space methodology using the SHELXT 
program.14 All non-hydrogen atoms were obtained from the initial solution. The 
hydrogen atoms for complex 2.7 were introduced at idealized positions and were 
allowed to refine isotropically. The structural model was fit using full matrix least-
squares based on F2. The calculated structure factors included corrections for 
anomalous dispersion from the usual tabulation. The structure was refined using the 
SHELXL program from the SHELX suite of crystallographic software.15 Graphic plots 
were produced using the Mercury program suite.16  
 
Initial indexing of complex 2.8 indicated that the sample crystal was non-merohedrally 
twinned. The twin law was determined to be: 
            0.98961 -0.03862 -0.00825 
        0.04331   1.00934   0.01391 
             0.00875 -0.02604   0.99903 
which represents a -2.586° rotation about the [-2 -1 7] (reciprocal cell) or [-11 -6 15] 
(direct cell). The twin fraction was included as an adjustable parameter. The unit cell 
dimensions were determined from a symmetry constrained fit of 3050 reflections with 
5.84° < 2q < 51.24°. The data collection strategy was a number of ω and φ scans which 
collected data up to 56.776° (2q). The frame integration was performed using SAINT.12 
The resulting raw data was scaled and absorption corrected using a multi-scan 
averaging of symmetry equivalent data using TWINABS.17 The structure was solved 
by using a dual space methodology using the SHELXT program.14 All non-hydrogen 
atoms were obtained from the initial solution. The hydrogen atoms were introduced at 
idealized positions and were allowed to refine isotropically. The twin fraction refined 
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to a value of 0.29480(115). The structural model was fit to the data using full matrix 
least-squares based on F2. The calculated structure factors included corrections for 
anomalous dispersion from the usual tabulation. The structure was refined using the 
SHELXL program from the SHELX suite of crystallographic software.15 Graphic plots 
were produced using the Mercury program suite.16 See Table 2.5 for additional 
crystallographic data. 
 
Table 2.5. X-ray diffraction data collection and refinement details for compounds 2.7 
and 2.8. 
 2.7 2.8 
Formula C22H21BF2N4 C38H31BN4 
Formula Weight (g mol–1) 390.24 554.48 
Crystal Dimensions (mm) 0.363 × 0.195 × 0.155 0.223 × 0.186 × 0.101 
Crystal Colour and Habit purple prism red plate 
Crystal System monoclinic triclinic 
Space Group P 21/c P -1 
Temperature, (K) 110 110 
a, (Å) 12.335(3) 9.863(2) 
b, (Å)  12.866(3) 10.432(2) 
c, (Å)  12.803(2) 15.125(4) 
a, (°) 90 92.766(11) 
b, (°) 110.343(7) 91.008(12) 
g, (°) 90 103.191(9) 
V, (Å3) 1905.0(7) 1512.7(6) 
Z 4 2 
r (g cm–1) 1.361 1.217 
l, Å, (MoKa) 0.71073 0.71073 
µ, (cm–1) 0.095 0.072 
Diffractometer Type Bruker Kappa Axis 
Apex2 
Bruker Kappa Axis 
Apex2 
R1 0.0433 0.0670 
wR2 0.1198 0.1511 
R1 (all data) 0.0661 0.1425 
wR2 (all data) 0.1336 0.1851 
GOF 1.047 1.025 
R1=S(|Fo|–|Fc|)/SFo 
wR2=[S(w(Fo2–Fc2 )2)/S(wFo4)]½ 
GOF=[S(w(Fo2–Fc2 )2)/(No. of reflns. –No. of params.)]½ 
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2.4.3 Electrochemical Methods 
Cyclic voltammetry experiments were performed using a Bioanalytical Systems Inc. 
(BASi) Epsilon potentiostat and analyzed using BASi Epsilon software. Typical 
electrochemical cells consisted of a three-electrode setup including a glassy carbon 
working electrode, platinum counter electrode, and silver pseudo reference electrode. 
Experiments were run at 250 mV s–1 in degassed CH2Cl2 solutions of the analyte           
(~1 mM) and electrolyte (0.1 M [nBu4N][PF6]). Cyclic voltammograms were internally 
referenced against the ferrocene/ferrocenium redox couple (~1 mM internal standard) 
and corrected for internal cell resistance using the BASi Epsilon software. 
 
2.4.4 Synthetic Procedures 
BF2 Complex 2.7 
Under N2, formazan 2.6 (1.0 g, 3.0 mmol) was dissolved in 
dry toluene (100 mL). NEt3 (1.4 mL, 10 mmol) was then 
added dropwise and the solution was stirred for 5 mins. 
BF3•OEt2 (1.9 mL, 15 mmol) was then added, and the 
solution was heated at 80 °C for 18 h. The solution changed 
from dark red to dark purple during this time. The solution was then cooled to room 
temperature and H2O (20 mL) was added to quench any reactive boron-containing 
compounds. The solution was then washed with deionized H2O (3 ´ 50 mL), dried over 
MgSO4, gravity filtered and concentrated in vacuo. The resulting residue was purified 
by flash chromatography (CH2Cl2, neutral alumina) to afford the BF2 complex 2.2 as a 
dark purple microcrystalline solid. Yield = 0.98 g (86%). 1H NMR (399.8 MHz, CDCl3) 
d 7.99 (d, 3JHH = 8 Hz, 2H, Aryl CH), 7.80 (d, 3JHH = 8 Hz, 4H, Aryl CH),                         
7.29–7.26 (m, 6H, Aryl CH), 2.43 (s, 3H, CH3), 2.42 (s, 6H, CH3). 19F NMR                
(376.1 MHz, CDCl3) d -145.0 (q, 1JFB =  30 Hz). 11B NMR (128.3 MHz, CDCl3)                   
d 0.5 (t, 1JBF = 29 Hz). 13C{1H} NMR (101.6 MHz, CDCl3) d 149.0, 141.7, 140.0, 139.1, 
131.1, 129.6, 129.4, 125.4, 123.2, 21.34, 21.32. FT-IR (ATR, cm–1) 3033, 2916, 2858, 
1909, 1605, 1506, 1504, 1414, 1377, 1350, 1317, 1302. UV-Vis (Toluene):                       
N
N N
N
B
F F
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lmax = 317 nm (e = 21 900 M–1 cm–1), 532 nm (e = 20 200   M–1 cm–1). ESI-HRMS      
(+ve mode) calculated for [C22H21BF2N4]+: 390.1827, found 390.1841, difference:     
+3.6 ppm. 
 
Phenylacetylene Complex 2.8 
Under N2, phenylacetylene (0.13 mL, 1.1 mmol) was 
dissolved in dry THF (5 mL) in a greaseless Schlenk flask, 
cooled to -78 °C, and stirred for 30 min. n-BuLi                       
(1.6 M, 0.45 mL, 1.1 mmol) was added dropwise over 5 min 
and the solution was stirred for 1 h. The solution was then 
brought to room temperature, stirred for 30 min and added 
dropwise to a second greaseless Schlenk flask containing 
BF2 complex 2.7 (0.20 g, 0.50 mmol) dissolved in THF (10 mL). The solution was 
stirred for 2 h at room temperature and gradually changed colour from deep purple to 
red/orange. The solution was then quenched with deionized H2O (7 mL), extracted with 
Et2O (25 mL) and washed with deionized H2O (3 ´ 50 mL), dried over MgSO4, gravity 
filtered and concentrated in vacuo. The resulting residue was purified by flash 
chromatography (2:1 hexanes:CH2Cl2, silica gel) to afford complex 2.3 as a red/orange 
microcrystalline solid. Yield = 0.10 g (35%). 1H NMR (599.5 MHz, CDCl3)                           
d 8.01 (dm, 2H, J = 6 Hz, Aryl CH), 7.90 (dm, 4H, JHH = 6 Hz, Aryl CH),                              
7.28–7.19 (m, 16H, Aryl CH), 2.43 (s, 3H, CH3), 2.42 (s, 6H, CH3).                                        
11B NMR (128.3 MHz, CDCl3) d –11.8 (s). 13C{1H} NMR (101.6 MHz, CDCl3)                   
d 151.7, 143.3, 139.4, 138.7, 131.5, 131.3, 129.3, 128.5, 127.9, 127.5, 125.5, 125.2, 
124.4, 99.9, 77.2, 21.38, 21.35. FT-IR (ATR, cm–1) 3030, 2952, 2920, 2854, 2367, 
2341, 2187, 1598, 1491, 1489, 1442, 1350, 1280. UV-Vis (Toluene): lmax = 320 nm        
(e = 25 700 M–1 cm–1), 521 nm (e =  12 000 M–1 cm–1). ESI-HRMS (+ve mode) 
calculated for [C38H31BN4]+: 554.2642, found 554.2651, difference: +1.6 ppm. 
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4-methoxyphenylacetylene Complex 2.9 
Under N2, 4-methoxyphenylacetylene (0.22 g, 1.7 mmol) 
was dissolved in dry THF (5 mL) in a greaseless Schlenk 
flask, cooled to -78 °C, and stirred for 30 min. n-BuLi        
(1.6 M, 0.68 mL, 1.7 mmol) was added dropwise over 5 min 
and the solution was stirred for 1 h. The solution was then 
brought to room temperature and slowly changed from clear 
yellow to an opaque coffee-brown colour. The solution was 
stirred for 30 min, added dropwise to a second greaseless 
Schlenk flask containing BF2 complex 2.7 (0.30 g, 0.8 mmol) dissolved in THF (10 mL) 
and stirred for an additional 2 h. The resulting solution gradually changed from deep 
purple to red and finally brown. The solution was then quenched with deionized H2O 
(7 mL), extracted with Et2O and washed with deionized H2O (3 ´ 50 mL), dried over 
MgSO4, gravity filtered and concentrated in vacuo. The resulting residue was purified 
by flash chromatography (toluene, silica gel) to afford complex 2.4 as a red/brown film.                     
Yield = 0.08 g (17%). 1H NMR (399.8 MHz, CDCl3) d 8.00 (dm, 2H, JHH = 8 Hz, Aryl 
CH), 7.90 (dm, 4H, JHH = 12 Hz, Aryl CH), 7.28–7.26 (m, 2H, Aryl CH), 7.23–7.21          
(m, 4H, Aryl CH), 7.17–7.15 (m, 4H, Aryl CH), 6.73–6.71 (m, 4H, Aryl CH),                 
3.76 (s, 6H, OCH3), 2.42 (s, 3H, CH3), 2.41 (s, 6H, CH3). 11B NMR (128.3 MHz, 
CDCl3) d -11.8 (s). 13C{1H} NMR (101.6 MHz, CDCl3) d 159.0, 151.7, 143.3, 139.2, 
138.7, 132.9, 131.4, 129.2, 128.4, 125.6, 125.2, 116.8, 113.5, 99.7, 77.2, 55.2, 21.38, 
21.35. FT-IR (ATR, cm–1) 3038, 2956, 2926, 2854, 2189, 1605, 1508, 1464, 1441, 
1355, 1282. UV-Vis (Toluene): lmax = 317 nm (e = 23 400 M–1 cm–1), 519 nm                                    
(e = 12 500 M–1 cm–1). ESI-HRMS (+ve mode) calculated for [C40H35BN4O2]+: 
614.2853, found 614.2879, difference: +4.2 ppm. 
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4-trifluoromethylphenylacetylene Complex 2.10 
Under N2, 4-trifluoromethylphenylacetylene (0.28 mL,       
1.7 mmol) was dissolved in dry THF (5 mL) in a greaseless 
Schlenk flask, cooled to -78 °C, and stirred for 30 min.         
n-BuLi (1.6 M, 0.68 mL, 1.7 mmol) was added very slowly 
over 5 min and the solution was stirred for 1 h. While 
stirring, the solution changed from clear yellow to cloudy 
white. The solution was held at -78 °C and then added 
dropwise to a second greaseless Schlenk flask containing 
BF2 complex 2.7  (0.3 g, 0.8 mmol) dissolved in THF (10 mL) at -78 °C. The deep 
purple solution slowly turned orange/brown as the solution was brought from -78 °C 
to room temperature and stirred for 2 h. The solution was then quenched with deionized 
H2O (7 mL), extracted with Et2O and washed with deionized H2O (3 ´ 50 mL), dried 
over MgSO4, gravity filtered and concentrated in vacuo. The resulting residue was 
purified by flash chromatography (silica gel). The column was first flushed with 
hexanes (50 mL) to remove impurities, followed by toluene (50 mL) to afford complex 
2.5 as a purple/brown film. Yield = 0.09 g (17%). 1H NMR (399.8 MHz, CDCl3)                  
d 8.00 (dm, 2H, JHH = 8 Hz, Aryl CH), 7.85 (dm, 4H, JHH = 8 Hz, Aryl CH), 7.46 (dm, 
4H, JHH = 8 Hz, Aryl CH), 7.32–7.24 (m, 10H, Aryl CH), 2.43 (m, 9H, CH3). 19F NMR         
(376.1 MHz, CDCl3) d -62.8 (s). 11B NMR (128.3 MHz, CDCl3) d -12.0 (s).           
13C{1H} NMR (101.6 MHz, CDCl3) d 152.1, 143.1, 139.7, 139.1, 131.7, 130.9, 129.5, 
129.4, 129.2, 128.6, 127.9, 125.5, 125.2, 124.9 (q, 1JCF = 16 Hz), 122.6, 98.6, 77.2, 
21.38, 21.36. FT-IR (ATR, cm–1) 3043, 2976, 2926, 2872, 2188, 1926, 1615, 1506, 
1405, 1320, 1278, 1263. UV-Vis (Toluene): lmax = 317 nm (e = 24 900 M–1 cm–1),              
521 nm (e = 13 700 M–1 cm–1). ESI-HRMS (+ve mode) calculated for [C40H29BF6N4]+: 
690.2389, found 690.2403, difference: +2.0 ppm. 
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Chapter 3 
3.1 Introduction 
Upon the successful synthesis of alkynyl-substituted boron formazanate complexes 
described in Chapter 2, the focus was shifted toward employing the alkynyl 
functionality as a handle toward post-synthetic modifications and the incorporation of 
redox-active species. Redox-active molecular systems have seen widespread use in 
applications such as electrochemical and pH sensing.1,2,3 Interesting systems exhibiting 
these unique properties include redox-active BODIPYs containing ferrocene 
functionalities.4,5 For example, the Zhu group developed a ferrocene-containing 
BODIPY (3.1) that exhibited unique electrochromism and provided a handle for 
sensing.6 
 
 
 
The authors took advantage of the electrochemical reversibility of ferrocene in order to 
modulate the electronics of the BODIPY core. Initially, UV-Vis absorption 
spectroscopy indicated complex 3.1 had a lmax value of 700 nm. Cyclic voltammetry 
revealed that oxidation of the ferrocene functionalities at roughly 0.5 V (vs. Ag/Ag+) 
was two distinct peaks (each corresponding to one-electron) at lower scan rates, 
indicating that the second ferrocene unit was more difficult to oxidize than the first as 
a result of this electronically conjugated system. A spectrochemical experiment was 
N B N
FF
3.1
FeFe
I
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then carried out where an oxidative potential of 0.7 V (vs. Ag/Ag+) was applied in order 
to oxidize both ferrocene moieties. UV-Vis absorption spectra displayed the lmax of 700 
nm slowly decreasing while a new lmax was observed at 600 nm as the oxidation 
proceeded, corresponding to a colour change of the solution from deep blue to red. 
When a reduction potential was applied (0 V vs. Ag/Ag+), the solution returned to deep 
blue and the lmax of 700 nm was regenerated, demonstrating the reversibility of the 
system. Interestingly, it was found that upon exposure of this BODIPY system to Cu2+ 
ions in a copper(II)perchlorate solution, the lmax of 700 nm in the UV-Vis absorption 
spectrum decreased, with an appearance of a new peak at roughly 550 nm, producing 
similar results to the electrochemically oxidized UV-Vis spectrum. As a result, the 
unique electrochromic properties of this system allowed the authors to demonstrate the 
potential use of this BODIPY system in metal ion sensing.  
 
The Gilroy group has also explored redox-active systems synthesized via Cu(I)-
catalyzed alkyne-azide cycloaddition (CuAAC) chemistry in order to modify a 
fluorescent BF2 formazanate (3.2) with a redox-active handle. A ferrocene-
functionalized BF2 formazanate (3.3) was synthesized via CuAAC with BF2 
formazanate 3.2 and ferrocenyl azide. UV-Vis absorption spectroscopy indicated 
complex 3.3 had a lmax value of 569 nm and was non-emissive in solution. Cyclic 
voltammetry revealed an oxidation event of two coincident one-electron waves 
corresponding to the ferrocene units occurred at 0.21 V (vs. ferrocene/ferrocenium). 
Interestingly, the coincident appearance of the oxidation indicated that there was little 
communication between the ferrocene units and the BF2 formazanate, likely as a result 
of the triazole ring. It was found that upon chemically oxidizing the ferrocene units of 
complex 3.3 with NOBF4, absorption maxima in the UV-Vis were blue-shifted by 
roughly 20 nm and an increase in emission intensity was observed (to a maximum of 
ΦF = 0.14), showcasing this system as a potential redox sensor.  
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Chapter 3 presents the synthesis and characterization of a redox-active alkynyl-
substituted boron formazanate complex, and explores the chemical oxidation and 
reduction of this system. It also explores the post-synthetic functionalization of a boron 
formazanate complex bearing a free terminal acetylene at the boron centre using 
CuAAC chemistry.   
 
3.2 Results & Discussion 
3.2.1 Synthesis of a Redox-Active Alkynyl-Substituted Boron 
Formazante Complex  
 
A redox-active alkynyl-substituted boron formazanate complex was synthesized 
according to Scheme 3.1. First, a solution of 2.7 was dissolved in dry THF and stirred 
for 15 min at room temperature. Separately, 2.2 equiv. of ethynylferrocene (3.4) was 
dissolved in dry THF, cooled to -78 °C and stirred for 30 min. 2.2 equiv. of n-BuLi 
was then added dropwise and the solution was stirred at -78 °C for 1 h, warmed to room 
temperature and stirred for an additional 30 min. The lithiated terminal acetylene was 
then added dropwise to the solution of compound 2.7 in THF and the resulting solution 
was stirred for 2 h. 
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Scheme 3.1. Synthesis of redox-active boron formazanate complex 3.5. Yield is 
indicated in brackets. 
 
The formation of complex 3.5 was accompanied by a colour change from deep purple 
to red/orange upon the addition of the acetylene/n-BuLi solution to 2.7, and the complex 
was isolated in 19% yield. The formation of 3.5 was accompanied by a disappearance 
of the 1:1:1:1 quartet in the 19F NMR spectrum as well as the disappearance of the 1:2:1 
triplet at –0.50 ppm due to loss of the fluorine atoms, and appearance of a broad singlet 
in the 11B NMR spectrum at –11.8 ppm (Figures B1–B3). Further supporting the 
formation of this compound was a diagnostic signal in the IR spectrum at 2188 cm–1 
indicating the presence of an alkyne functionality (Figure 3.1). 
 
Figure 3.1. IR Spectrum of complex 3.5. Arrow indicates the internal alkyne stretch at 
2188 cm–1. 
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3.2.2 X-ray Crystallography 
Single crystals for X-ray diffraction studies were grown by slow vapour diffusion of 
pentane into a saturated CH2Cl2 solution (3.5) (Figure 3.2). Side views of the solid-state 
structures of the parent BF2 complex (2.7) and phenylacetylene complex (2.8) from 
Chapter 2 (Figure 3.2a,b) are included for comparison.  
 
              
 
Figure 3.2. Side-view solid-state structures of a) 2.7, b) 2.8. Top-view and side-view 
solid-state structures of c) 3.5. Thermal ellipsoids are shown at 50% probability and 
hydrogen atoms are removed for clarity. Some substituents in b) and c) have been 
converted to wireframe for clarity. a) and b) have been reproduced from Chapter 2 for 
comparison. 
 
 
a b 
c 
B1 
N3 N1 
N2 N4 
  
54 
The solid-state structures show that the boron atoms are four-coordinate and adopt a 
tetrahedral geometry. They also show a delocalized formazanate backbone with all C-
N and N-N bond lengths between those of typical single and double bonds (Table 3.1). 
The C-N bond lengths for all three compounds fall between 1.3385(8) and 1.352(2) Å, 
while typical C-N single and double bonds are 1.47 and 1.29 Å, respectively.7 The N-
N bond lengths fall between 1.3028(7) and 1.316(3) Å, while typical N-N single and 
double bonds are 1.45 and 1.25 Å. Complex 2.7 is relatively planar, with the boron 
atom displaced by 0.094 Å relative to the formazanate backbone, while the boron atoms 
of 2.8 and 3.5 are significantly further displaced by 0.713 Å and 0.755 Å, respectively, 
as a result of the large substituents bound to the boron centre. The 1,5-aryl substituents 
in complex 2.7 are slightly twisted with respect to the formazanate backbone, with the 
angle between the N1-N2-N3-N4 plane and the plane defined by the N-aryl substituents 
being 4.51 and 8.48°. Complexes 2.8 and 3.5 exist in a ‘dragonfly’ conformation where 
the dihedral angles between the 1,5-aryl substituents and formazanate backbone are 
significantly more twisted, with angles ranging from 54.9 to 67.9°. The ethynyl-
substituted complexes exhibit B-N bond lengths slightly longer than those of complex 
2.7, with bond lengths ranging from 1.573(3) and 1.581(3) Å compared to 1.560(9) and 
1.566(1) Å for 2.7, indicating the boron atom of the parent BF2 complex is strongly 
bound by the formazanate backbone. In contrast, the steric effects of the ethynyl-
substituted boron complexes are a likely cause of the elongated B-N bonds, which 
suggest the boron atoms are more weakly held by the formazanate backbone in these 
ethynyl-substituted complexes.  
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Table 3.1. Selected bond lengths (Å) and angles (°) of compounds 2.7, 2.8 and 3.5. 
 
 2.7 2.8	 	 3.5 
B1-N1 1.566(1) 1.575(4)	 	 1.576(3) 
B1-N3 1.560(9) 1.573(3)	 	 1.581(3) 
N1-N2 1.3037(7) 1.312(3)	 	 1.313(2) 
N3-N4 1.3028(7) 1.316(3)	 	 1.308(2) 
C1-N2 1.3417(8) 1.346(3)	 	 1.343(2) 
C1-N4 1.3385(8) 1.344(3)	 	 1.352(2) 
Dihedral Anglesa 4.51, 8.48 54.92, 60.60	 	 66.87, 67.92 
Boron Displacementb 0.094 0.713	 	 0.755 
aThe angle (°) between the N-aryl substituents and the N4 plane of the formazanate 
backbone. bDistance (Å) between B1 and the plane defined by the four N atoms. 
 
3.2.3 Electrochemical Properties 
The electrochemical properties of 3.5 were explored using cyclic voltammetry and are 
summarized in Table 3.2 along with complexes 2.7 and 2.8 for comparison. 
Experiments were performed in dry, degassed CH2Cl2 and the cyclic voltammograms 
are shown in Figure 3.3. Complexes 2.7, 2.8 and 3.5 exhibited two ligand-centred 
reversible (or quasi-reversible) one-electron reduction waves at E°red1 = -1.04, -1.18, 
-1.21 V and E°red2 = -1.99, -2.03 and -2.13 V, respectively, relative to the 
ferrocene/ferrocenium redox couples. All three complexes also exhibited one quasi-
reversible oxidation wave at E°ox1 = 1.03, 0.83 and 0.89, respectively. In addition, 
complex 3.5 exhibited another reversible oxidation at a lower potential (E°Fc = 0.03 V). 
This additional oxidation was a two electron process and corresponded to the coincident 
oxidation of the two ferrocene moieties. 
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Table 3.2. Summary of the electrochemical properties of compounds 2.7, 2.8 and 
3.5.a 
Compound E°red1 (V) E°red2 (V)b E°Fc (V) E°ox1 (V) 
2.7 -1.04 -1.99 - 1.03 
2.8 -1.18 -2.03 - 0.83 
3.5 -1.21 -2.13 0.03 0.89 
aCyclic voltammograms were recorded in dry, degassed CH2Cl2 containing ~1 mM 
analyte and 0.1M [nBu4N][PF6] as a supporting electrolyte at a scan rate of 250 mV s-1. 
Compounds 2.7, 2.8 and 3.5 was referenced internally against the 
ferrocene/ferrocenium redox couple. bReduction peaks are not reversible and the values 
listed are of the maximum cathodic current. 
 
 
Figure 3.3. Cyclic voltammograms of compounds 2.7 (blue), 2.8 (red) and 3.5 (green) 
recorded in dry, degassed CH2Cl2 containing ~1 mM analyte and 0.1 M [nBu4N][PF6] 
as a supporting electrolyte at a scan rate of 250 mV s-1. Arrows indicate the direction 
of scan.  
 
Relative to the parent BF2 complex (2.7), 3.5 was found to be more difficult to reduce 
and easier to oxidize as it lacks electronegative fluorine groups, following the trend 
observed in complex 2.8 and others from Chapter 2. The first oxidation wave of 
compound 3.5 (Figure 3.3, green) is a two ´ one-electron process and may be attributed 
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to oxidation of the ferrocene moieties. The coincidence or near coincidence of the 
waves indicates that there is little or no communication between the two ferrocene 
substituents through the boron atom, as both ferrocene moieties oxidize at the same (or 
nearly the same) potential. The second oxidation wave was found to become more 
reversible upon an increase of the scan rate. Based on the information obtained from 
the cyclic voltammograms, appropriate oxidants and reductants were selected in order 
to probe the chemically reduced and oxidized forms of the ferrocene complex 3.5. 
 
 
3.2.4 Reduced & Oxidized Forms of Redox-Active Complex 
3.5 
The reduced form of the redox-active boron formazanate complex was isolated by first 
dissolving 1 equiv. of bis(pentamethylcyclopentadienyl)cobalt(II) (CoCp*2) in toluene 
and stirring for 15 min in a glovebox (Scheme 3.2). The CoCp*2 solution was then added 
dropwise to a stirring solution of complex 3.5 in dry toluene and the resulting solution 
turned from deep purple to an emerald green suspension. The suspension was stirred 
for 4 h, vacuum filtered and the resulting green solid was washed with 5 mL toluene 
followed by 10 mL pentane before it was dried in vacuo to afford the final reduced 
complex 3.6 in 89% yield. 
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Scheme 3.2. Synthesis of the reduced ferrocene-containing boron formazanate complex 
3.6. 
 
 
In order to achieve an accurate basis for comparison, reduction of the phenylacetylene 
complex from Chapter 2 (2.8) was carried out using cobaltocene (CoCp2) (Scheme 3.3) 
under the same conditions described above for reduction of the ferrocene complex 
(Scheme 3.2). While the reduced phenylacetylene complex 3.7 was a green powder 
with the CoCp2+ counter ion, CoCp*2 was used for the reduced ferrocene complex 3.6 
to increase crystallinity of the sample in an effort to explore its X-ray crystallographic 
properties. 
 
 
Scheme 3.3. Synthesis of the reduced phenylacetylene complex 3.7. 
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The oxidized form of the ferrocene complex 3.5 was isolated by first dissolving 
complex 3.5 in a 1:1 mixture of dry MeCN and dry CH2Cl2 in a glovebox and stirring 
at room temperature for 15 min (Scheme 3.4). Separately, 2 equiv. of tris(4-
bromophenyl)ammoniumyl hexachloroantimonate (magic blue) was dissolved in 
MeCN and stirred for 15 min. The magic blue solution was then added dropwise to the 
solution containing 3.5 and the resulting solution turned from deep purple to dark green. 
The solution was then stirred for 4 h to afford the final oxidized complex 3.8 in 90% 
yield. 
 
 
Scheme 3.4. Synthesis of the oxidized ferrocene-containing boron formazanate 
complex 3.8. 
 
3.2.5 UV-Visible Absorption Spectroscopy 
The UV-Visible absorption spectra of compounds 3.5, 3.6 and 3.8 are shown in Figure 
3.4 and summarized in Table 3.3. All three compounds absorb in the visible region of 
the electromagnetic spectrum, with significant changes to the absorbance spectrum 
upon reduction or oxidation of complex 3.5. 
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Figure 3.4. UV-Visible absorption spectra of compounds 3.5, 3.6 and 3.8 recorded for 
degassed 10 µM CH3CN solutions.  
 
 
Upon reduction with CoCp*2, complex 3.6 exhibits a longer-wavelength absorption 
(~775 nm) as well as peaks at 470 and 294 nm, providing evidence for a singly reduced 
formazanate backbone, which agrees with previous reports.8,9 The position of these 
peaks is also similar to those reported for triarylverdazyls.10 Furthermore, the formation 
of a singly reduced formazanate backbone is supported by the UV trace of the reduced 
phenylacetylene complex 3.7 compared to its neutral parent complex 2.8 shown in 
Figure 3.5 and summarized in Table 3.4.  
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Figure 3.5. UV-Visible absorption spectra of compounds 2.8 and 3.7 recorded for 
degassed 10 µM CH3CN solutions.  
 
The reduction of complex 2.8 exhibits a similar UV trace to the reduction of complex 
3.7, as a longer-wavelength absorption is observed as well as blue-shifted absorption 
maxima at 465 and 308 nm. 
 
Table 3.3. Spectroscopic properties of complexes 3.5, 3.6 and 3.8. 
Compound Solvent lmaxa, nm, (e, M-1 cm–1) 
3.5 CH3CN 271 (35 200), 309 (24 300), 501 (11 150) 
3.6 CH3CN 
 
294 (43 450), 470 (9600), 775 (2700), 830 (2350) 
3.8 CH3CN 
 
264 (27 700), 320 (21 100), 541 (11 300) 
aValues recorded for degassed 10 µM solutions. 
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Table 3.4. Spectroscopic properties of complexes 2.8 and 3.7. 
Compound Solvent lmaxa, nm, (e, M-1 cm–1) 
2.8 CH3CN 257 (45 800), 312 (21 000), 504 (10 800) 
3.7 CH3CN 260 (70 400), 308 (23 300), 465 (11 900), 787 
(3800), 826 (3450) 
aValues recorded for degassed 10 µM solutions. 
 
Further supporting the presence of radical complexes 3.6 and 3.7 is a broad, featureless 
signal present in each of the electron paramagnetic resonance (EPR) spectra at                        
g = 2.0035 (Figure 3.6a, b), similar to other ligand-centred boron formazanate 
radicals.9,10  
 
 
Figure 3.6. EPR spectra of a) 3.6 and b) 3.7 in degassed THF at 298 K (g = 2.0035). 
 
Upon oxidation of complex 3.5 with magic blue, the absorption spectrum of 3.8 exhibits 
a red-shift of 40 nm in the p®p* region from 501 to 541 nm (Figure 3.4). Furthermore, 
complex 3.8 did not produce a signal in the EPR spectrum at 298 K, as the ferrocenium 
cation is not detected above 77 K as a result of fast spin-lattice relaxation.11  
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3.2.6 Post-synthetic Functionalization via Cu(I)-Catalyzed 
Click Chemistry 
CuAAC chemistry was explored using the terminal acetylene at the boron centre as the 
functional handle in order to further expand the scope of boron formazanate chemistry. 
Boron-acetylene complex 3.10 was synthesized by first dissolving 2.2 equiv. of 
trimethylsilylacetylene in dry THF, cooling to -78 °C and stirring for 30 min (Scheme 
3.5). 2.2 equiv. of n-BuLi was then added dropwise and the solution was stirred at -78 
°C for 1 h. The solution was held at -78 °C and added dropwise to a solution of 2.7 
dissolved in dry THF at -78 °C. The deep purple solution slowly turned red/orange as 
the solution was brought from -78 °C to room temperature and stirred for 3 h. Complex 
3.9 was then added to a solution of 11 equiv. of K2CO3 in MeOH and stirred for 4 h at 
room temperature to afford the final boron-acetylene complex 3.10 in 84% yield. 
 
 
Scheme 3.5. Synthesis of boron acetylene complex 3.10. 
 
The formation of complex 3.9 was accompanied by the appearance of a large singlet at 
0.05 ppm in the 1H NMR spectrum corresponding to the TMS groups (Figure 3.8, top). 
A disappearance of the 1:1:1:1 quartet in the 19F NMR spectrum and a disappearance 
of the 1:2:1 triplet and appearance of a broad singlet in the 11B NMR spectrum were 
also observed (Figures B4–B5), indicating the fluorine atoms were no longer present. 
The formation of complex 3.10 was accompanied by the disappearance of the TMS 
signal at 0.05 ppm in the 1H NMR spectrum and the appearance of the terminal 
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acetylene protons at 2.23 ppm (Figure 3.8, middle, Figures B6–B7). Further supporting 
the formation of this compound was two diagnostic signals in the IR spectrum 
indicating the presence of a terminal acetylene at 3281 and 2060 cm–1 (Figure 3.7). 
 
 
Figure 3.7. IR spectrum of compound 3.10. Arrows indicate the terminal acetylene 
functionality at 3281 and 2060 cm–1. 
 
As a proof of concept, benzyl azide (3.11) was used as a model reactant for the CuAAC 
reaction with complex 3.10 to afford the cycloaddition product 3.12 (Scheme 3.6). 
 
 
Scheme 3.6. CuAAC reaction with benzyl azide. 
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diagnostic benzyl protons at 5.36 ppm, as well as a signal corresponding to the protons 
of the triazole rings at 8.07 ppm (Figure 3.8 bottom, Figures B8–B9). Further 
supporting the formation of the cycloaddition product was the disappearance of the 
acetylene stretches at 3281 and 2060 cm–1 from the IR spectrum of 3.10 (Figure 3.9, 
black) to 3.12 (Figure 3.9, blue). The IR spectrum also confirmed the consumption of 
benzyl azide (Figure 3.9, red), as no azide stretch was present at 2095 cm–1 in the 
spectrum of 3.12 (Figure 3.9, black). 
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Figure 3.8. 1H NMR spectra of compounds 3.9 (top), 3.10 (middle) and 3.12 (bottom) 
in CDCl3. Red highlights on structures indicate protons of interest. 
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Figure 3.9. IR spectra of compounds 3.10 (black), 3.11 (red) and 3.12 (blue). 
 
3.2.7 UV-Visible Absorption Spectroscopy  
The UV-Visible absorption spectra of compounds 3.10 and 3.12 are shown in Figure 
3.10 and relevant data are summarized in Table 3.5. Both compounds absorb in the 
visible region of the electromagnetic spectrum with the cycloaddition product 
exhibiting a slight red-shift in the p®p* region from 524 to 532 nm. The slight red-
shift observed is in agreement with previous reports of similar BF2 formazanate systems 
in which red-shifts of up to 30 nm were observed in cycloaddition products.12 
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Figure 3.10. UV-Visible absorption spectra of compounds 3.10 and 3.12 recorded for 
degassed 10 µM toluene solutions. 
 
Table 3.5. Spectroscopic properties of complexes 3.10 and 3.12. 
Compound Solvent lmaxa, nm, (e, M-1 cm–1) 
3.10 Toluene 317 (28 500), 524 (16 900) 
3.12 Toluene 
 
295 (36 000), 532 (14 000) 
aValues recorded for degassed 10 µM solutions. 
 
3.3 Conclusions 
Through the ethynyl moiety it has been demonstrated that functionality can be 
introduced at the boron centre including redox-active handles and functional groups 
capable of undergoing post-synthetic modification. The first reported alkynyl-
substituted boron formazanate complex bearing a redox-active ferrocene moiety was 
synthesized, and its optical and spectroscopic properties were explored alongside the 
chemically oxidized and reduced forms of the parent system (3.5, 3.6 and 3.8) and the 
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reduced phenylacetylene complex 3.7. X-ray crystallography revealed an elongation of 
the B-N bonds upon incorporation of the ethynylferrocene moiety (3.5) at the boron 
atom, and all C-N and N-N bond lengths were found to be between those of typical 
single and double bonds, indicating a significant degree of electronic delocalization. 
The boron atoms were found to be significantly displaced from the plane of the 
formazanate backbone, as the displacement in the parent BF2 (2.7) was found to be 
0.094 Å while the displacement in the ethynylferrocene complex (3.5) and 
phenylacetylene complex (2.8) was found to be 0.755 and 0.713 Å, respectively. 
Significant twisting of the N-aryl substituents on the formazanate backbone was also 
observed as a result of the increased steric bulk at the boron centre, with complexes 2.8 
and 3.5 existing in a ‘dragonfly’ conformation where the dihedral angles between the 
1,5-aryl substituents and the formazanate backbone were found to be 54.9 and 67.9°. 
IR spectroscopy confirmed the presence of an internal alkyne at 2188 cm–1 for complex 
3.5. The three ferrocene complexes (3.5, 3.6 and 3.8) were found to absorb within the 
visible region of the electromagnetic spectrum, with drastic changes to the absorbance 
spectrum upon chemical reduction or oxidation of the parent complex 3.5. A similar 
trend was observed upon the chemical reduction of the neutral phenylacetylene 
complex 2.8, showing a UV trace similar to that of the reduced ferrocene complex. 
Upon reduction of 3.5 with CoCp*2, a longer-wavelength absorption at 775 nm was 
observed alongside a blue-shift of the lmax from 501 in the parent complex to 470 nm, 
closely matching the UV trace of the similarly reduced phenylacetylene complex 3.7, 
providing evidence for a singly reduced formazanate backbone. EPR spectroscopy also 
confirmed the presence of a radical with g = 2.0035, similar to other ligand-centred 
formazanate radicals. Oxidation of the parent ferrocene complex with magic blue 
unexpectedly caused a red-shift of the lmax from 501 nm in the parent complex to         
541 nm. Cyclic voltammetry demonstrated that complex 3.5 was redox-active and 
exhibited two quasi-reversible one-electron reduction processes and two oxidation 
processes (one quasi-reversible, the other reversible) relative to the 
ferrocene/ferrocenium redox couple. Electrochemical data suggested complex 3.5 was 
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more difficult to reduce and easier to oxidize compared to the parent BF2 complex (2.7). 
The first oxidation wave of 3.5 was determined to be a two ´ one-electron process 
attributed to oxidation of the ferrocene moieties. The coincidence or near coincidence 
of the waves indicated little or no communication between the two ferrocene 
substituents through the boron atom.. The CuAAC reaction was also explored as a 
means to further modify the boron formazanate template. As a proof of concept, benzyl 
azide was used as a model reactant for the CuAAC reaction with boron acetylene 
complex 3.10. The cycloaddition product was successfully synthesized and 
characterized by the disappearance of terminal acetylene protons at 2.23 ppm in the       
1H NMR of the starting material and appearance of diagnostic benzyl protons at             
5.36 ppm and protons characteristic of the triazole rings at 8.07 ppm in the 
cycloaddition product (3.12). IR spectra revealed a disappearance of the terminal 
acetylene stretches at 3281 and 2060 cm–1, and comparison with the IR spectrum of 
benzyl azide confirmed no residual azide remained, confirming the successful synthesis 
of the cycloaddition product.  
 
3.4 Experimental 
3.4.1 General Considerations 
Solvents were obtained from Caledon Laboratories, dried using an Innovative 
Technologies Inc. solvent purification system, collected under vacuum, and stored 
under an N2 atmosphere over 4 Å molecular sieves. All other reagents were purchased 
from Sigma Aldrich, Alfa Aesar or Oakwood Chemical and used as received. NMR 
spectra were recorded on a Bruker 400 MHz NMR spectrometer, 400 MHz Varian 
INova NMR spectrometer, or 600 MHz Varian Inova NMR spectrometer. 1H NMR 
spectra were recorded in CDCl3 and referenced against residual protonated solvent at 
7.27 ppm. 13C{1H} NMR spectra were referenced to CDCl3 at 77.0 ppm. 
11B NMR 
spectra were referenced internally to BF3•OEt2 at 0 ppm. 19F NMR spectra were 
referenced internally to CFCl3 at 0 ppm. Mass spectra were recorded in positive-ion 
mode using a high-resolution Finnigan MAT 8200 spectrometer. UV-Vis absorption 
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spectra were recorded using a Cary 5000 Scan instrument using standard quartz cells 
(1 cm path length) with a scan range of 200 to 800 nm. Samples were dissolved in 
spectroscopic grade solvents to obtain various concentrations. The background was 
subtracted from each spectrum and the solvent used for each experiment is indicated. 
FT-IR spectra were recorded using a Perkin Elmer Spectrum Two FT-IR spectrometer. 
 
3.4.2 X-ray Crystallography Methods 
Single crystals suitable for X-ray diffraction studies were grown by slow vapour 
diffusion of pentane into a saturated CH2Cl2 solution (3.5) and were analyzed by Ryan 
Maar. Samples were mounted on a MiTeGen polyimide micromount with a small 
amount of Paratone N oil. X-ray measurements were made on a Bruker Kappa Axis 
Apex2 diffractometer or Nonius KappaCCD Apex2 diffractometer at a temperature of 
110 K. The unit cell dimensions of complex 3.5 were determined from a symmetry 
constrained fit of 9882 reflections with 7.64° < 2q < 131.94°. The data collection 
strategy was a number of ω and φ scans which collected data up to 132.764° (2q). The 
frame integration was performed using SAINT.13 The resulting raw data was scaled and 
absorption corrected using a multi-scan averaging of symmetry equivalent data using 
SADABS.14 The structure was solved by using a dual space methodology using the 
SHELXT program.15 All non-hydrogen atoms were obtained from the initial solution. 
The hydrogen atoms for complex 3.5 were introduced at idealized positions and were 
allowed to ride on the parent atom. The structural model was fit to both sets of data 
using full matrix least-squares based on F2. The calculated structure factors included 
corrections for anomalous dispersion from the usual tabulation. The structures were 
refined using the SHELXL program from the SHELX suite of crystallographic 
software.16 Graphic plots were produced using the Mercury program suite.17 See 
Appendix B for additional crystallographic data. 
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Table 3.6. X-ray diffraction data collection and refinement details for compound 3.5. 
 3.5 
Formula C46H39BFe2N4 
Formula Weight (g mol–1) 770.32 
Crystal Dimensions (mm) 0.612 × 0.227 × 0.224 
Crystal Colour and Habit red prism 
Crystal System monoclinic 
Space Group P 21/c 
Temperature, (K) 110 
a, (Å) 13.8977(15) 
b, (Å)  14.8248(19) 
c, (Å)  18.489(2) 
a, (°) 90 
b, (°) 92.527(5) 
g, (°) 90 
V, (Å3) 3805.6(8) 
Z 4 
r (g cm–1) 1.344 
l, Å, (CuKa) 1.54178 
µ, (cm–1) 6.401 
Diffractometer Type Nonius Kappa CCD 
Apex2 
R1 0.0312 
wR2 0.0786 
R1 (all data) 0.0351 
wR2 (all data) 0.0804 
GOF 1.029 
R1=S(|Fo|–|Fc|)/SFo 
wR2=[S(w(Fo2–Fc2 )2)/S(wFo4)]½ 
GOF=[S(w(Fo2–Fc2 )2)/(No. of reflns. –No. of params.)]½ 
 
 
3.4.3 Electrochemical Methods 
Cyclic voltammetry experiments were performed using a Bioanalytical Systems Inc. 
(BASi) Epsilon potentiostat and analyzed using BASi Epsilon software. Typical 
electrochemical cells consisted of a three-electrode setup including a glassy carbon 
working electrode, platinum counter electrode, and silver pseudo reference electrode. 
Experiments were run at 250 mV s–1 in degassed CH2Cl2 solutions of the analyte           
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(~1 mM) and electrolyte (0.1 M [nBu4N][PF6]). Cyclic voltammograms were internally 
referenced against the ferrocene/ferrocenium redox couple (~1 mM internal standard) 
and corrected for internal cell resistance using the BASi Epsilon software. Ferrocene 
complex 3.5 was internally referenced against the ferrocene/ferrocenium redox couple 
using decamethylferrocene/decamethylferrocenium (−520 mV vs ferrocene/ 
ferrocenium). 
 
3.4.4 Electron Paramagnetic Resonance Spectroscopy 
EPR measurements were made for degassed 10 µM THF solutions of radical anions 
3.6•– and 3.7•– using a JEOL JES-FA200 EPR spectrometer. All measurements were 
made at 25 °C and g-values were referenced relative to a built-in Mn2+ marker within 
the resonant cavity of the instrument. 
 
3.4.5 Synthetic Procedures 
Ferrocene Complex 3.5 
Under N2, ethynyl ferrocene (0.36 g, 1.7 mmol) was 
dissolved in in dry THF (5 mL) in a greaseless Schlenk flask, 
cooled to -78 °C and stirred for 30 min. n-BuLi (0.68 mL, 
1.7 mmol) was added dropwise over 5 min and the solution 
was stirred for 1 h. The solution was then brought to room 
temperature and stirred for 30 min before it was added 
dropwise to a second greaseless Schlenk flask containing BF2 
complex 2.7 (0.31 g, 0.79 mmol) dissolved in THF (10 mL). 
The solution was then stirred at room temperature for 2 h and quenched with deionized 
H2O (7 mL), the organics were extracted with Et2O and washed with deionized H2O         
(3 ´ 50 mL), dried over MgSO4, gravity filtered and concentrated in vacuo. The 
resulting residue was purified by flash chromatography (silica gel). The column was 
first flushed with hexanes (150 mL) to remove impurities, followed by toluene (50 mL) 
to afford the resulting complex 3.5 as a green/blue microcrystalline solid.                       
FeFe
N
N N
N
B
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Yield = 0.12 g (19%). 1H NMR (399.8 MHz, CDCl3) d 8.04 (dm, 2H, JHH = 4 Hz,               
Aryl CH), 7.90 (dm, 4H, JHH = 12 Hz, Aryl CH), 7.30–7.26 (m, 6H, Aryl CH),                      
4.22 (t, 4H, JHH = 4 Hz, Aryl CH), 4.05 (t, 4H, JHH = 4 Hz, Aryl CH), 3.92 (s, 10H,                   
Aryl CH), 2.42 (s, 9H, CH3). 11B NMR (128.3 MHz, CDCl3) d -11.8 (s). 13C{1H} NMR 
(101.6 MHz, CDCl3) d 151.8, 143.4, 139.2, 138.7, 131.4, 129.3, 128.4, 125.6, 125.1, 
98.2, 77.2, 71.2, 69.6, 68.0, 66.6, 21.39, 21.36. FT-IR (ATR, cm–1) 3093, 3037, 2957, 
2923, 2854, 2358, 2189, 1739, 1605, 1506, 1456, 1353, 1282, 1263. UV-Vis (CH3CN): 
lmax = 271 nm (e = 35 200 M–1 cm–1), 309 nm (e = 24 300 M–1 cm–1), 501 nm                          
(e = 11 150 M–1 cm–1). ESI-HRMS (+ve mode) calculated for [C46H39BFe2N4]+: 
770.1967, found 770.1977, difference: +1.2 ppm. 
 
Reduced Ferrocene Complex 3.6 
In an N2 filled glovebox, complex 3.5 (0.18 g,        
0.23 mmol) was dissolved in toluene (15 mL) and 
stirred for 15 min. Separately, bis 
(pentamethylcyclopentadienyl) cobalt(II) (0.075 g, 
0.23 mmol) was dissolved in toluene (6 mL) and 
stirred for 15 min. This solution was then added 
dropwise to the solution of complex 3.5 and stirred 
for 4 h. The resulting emerald green suspension was 
then vacuum filtered, and the solid was washed with 
toluene (5 mL) followed by pentane (10 mL) before the microcrystalline green powder 
was dried in vacuo. Yield = 0.27 g (89%). FT-IR (ATR, cm–1) 3096, 3078, 3021, 2991, 
2958, 2916, 2853, 2156, 1716, 1602, 1501, 1374, 1334. UV-Vis (CH3CN):                       
lmax = 294 (e = 43 450 M–1cm–1), 470 (e = 9600 M–1cm–1), 767 (e = 2700 M–1 cm–1),   
833 (e = 2350 M–1 cm–1) nm. ESI-HRMS (–ve mode) calculated for                          
[C46H39BFe2N4]–: 770.1972, found 770.1967, difference: +0.7 ppm. 
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Reduced Phenylacetylene Complex 3.7 
In a N2 filled glovebox, complex 2.8 (0.29 g,     
0.51 mmol) was dissolved in toluene (15 mL) and 
stirred for 15 min. Separately, bis 
(cyclopentadienyl)cobalt (II) (0.10 g, 0.51 mmol) 
was dissolved in toluene (6 mL) and stirred for      
15 min. The solution was then added dropwise to 
the solution of complex 2.8 and stirred for 4 h. The 
resulting brown/green suspension was then vacuum filtered, and the solid was washed 
with toluene (5 mL) followed by pentane (10 mL) to afford complex 3.7 as a green 
powder. Yield = 0.31 g (81%). FT-IR (ATR, cm–1) 3098, 3015, 2919, 2858, 1500, 1485, 
1415, 1327, 1278, 1260. UV-Vis (CH3CN): lmax = 260 (e = 70 400 M–1 cm–1),  308 (e 
= 23 300 M–1 cm–1), 465 (e = 11 900 M–1 cm–1), 787 (e  = 3800 M–1 cm–1), 826 nm (e = 
3450 M–1 cm–1). ESI-HRMS (–ve mode) calculated for [C38H31BN4]–: 554.2647, found 
554.2642, difference: +0.9 ppm. 
 
Oxidized Ferrocene Complex 3.8 
In an N2 filled glovebox, complex 3.5 (0.10 g,    
0.13 mmol) was dissolved in MeCN (7 mL) and 
CH2Cl2 (7 mL) and stirred for 15 min. 
Separately, tris(4-bromophenyl) ammoniumyl 
hexachloroantimonate (0.22 g, 0.27 mmol) was 
dissolved in acetronitrile (6 mL) and stirred for 
15 min. The solution was then added dropwise 
to the solution of complex 3.5 and stirred for         
4 h. The purple suspension was then 
concentrated in vacuo and the resulting residue was purified by flash chromatography 
(CH2Cl2, alumina) to remove impurities followed by THF to afford complex 3.8 as a 
purple film. Yield = 0.17 g (90%). FT-IR (ATR, cm–1) 3033, 2973, 2924, 2857, 1894, 
N
N N
N
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FeFe
N
N N
N
B
2
2 SbCl6
  
76 
1579, 1484, 1310, 1282, 1264. UV-Vis (CH3CN): lmax = 264 (e = 27 700 M–1 cm–1),                              
321 (e = 21 100 M–1 cm–1), 541 nm (e = 11 300 M–1 cm–1). 
 
TMS-acetylene Complex 3.9 
Under N2, trimethylsilylacetylene (0.27 mL, 1.9 mmol) was 
dissolved in dry THF (5 mL) in a greaseless Schlenk flask, 
cooled to -78 °C and stirred for 30 min. n-BuLi (0.79 mL, 
1.9 mmol) was added very slowly over 5 min and the 
solution was stirred for 1h. The solution was held at - 78 °C 
and then added dropwise to a second greaseless Schlenk 
flask containing BF2 complex 2.7  (0.35 g, 0.90 mmol) 
dissolved in THF (10 mL) at -78 °C. The deep purple solution slowly turned red/orange 
as the solution was warmed from -78 °C to room temperature and stirred for 3 h. The 
solution was then quenched with deionized H2O (7 mL), the organics were extracted 
with Et2O and washed with deionized H2O (3 ´ 50 mL), dried over MgSO4, gravity 
filtered and concentrated in vacuo. The resulting residue was purified by flash 
chromatography (toluene, silica gel) to afford the resulting complex 3.9 as a 
purple/brown film. Yield = 0.15 g (31%). 1H NMR (399.8 MHz, CDCl3)                                   
d 7.92 (dm, 2H, JHH = 8 Hz, Aryl CH), 7.77 (dm, 4H, JHH = 8 Hz, Aryl CH), 7.24 (dm, 
2H, JHH = 8 Hz, Aryl CH), 7.16 (dm, 4H, JHH = 8 Hz, Aryl CH), 2.40 (s, 3H, CH3), 2.38 
(s, 6H, CH3), –0.05 (s, 18H, CH3). 11B NMR (128.3 MHz, CDCl3) d –13.2 (s). 13C{1H} 
NMR (101.6 MHz, CDCl3) d 152.6, 142.8, 139.2, 138.8, 131.0, 129.1, 128.3, 125.7, 
125.3, 106.8, 77.2, 21.4, 21.3, –0.3. FT-IR (ATR, cm–1) 3035, 2957, 2923, 2897, 2857, 
2132, 1605, 1505, 1351, 1260, 1247, 1209. UV-Vis (Toluene): lmax = 317 (e = 25 100                
M–1 cm–1), 515 nm (e = 14 200 M–1 cm–1). ESI-HRMS (+ve mode) calculated for 
[C32H39BN4Si2]+: 546.2806, found 546.2770, difference: –6.5 ppm. 
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Acetylene Complex 3.10 
In air, complex 3.9 (0.41 g, 0.74 mmol) was dissolved in 
warm MeOH (50 mL). K2CO3 (1.5 g, 11 mmol) was added 
and the solution was stirred at room temperature for 4 h. The 
solution was then concentrated in vacuo and the resulting 
residue was extracted with Et2O and deionized H2O                    
(3 ´ 50 mL), dried over MgSO4, gravity filtered and 
concentrated in vacuo. The resulting residue was purified by flash chromatography         
(1:1 hexanes:CH2Cl2, silica gel) to afford the resulting complex 3.10 as a purple film.          
Yield = 0.25 g (84%). 1H NMR (399.8 MHz, CDCl3) d 7.97 (dm, 2H, JHH = 8 Hz, Aryl 
CH), 7.76 (dm, 4H, JHH = 8 Hz, Aryl CH), 7.27 (dm, 2H, JHH = 8 Hz, Aryl CH), 7.23 
(dm, 4H, JHH = 8 Hz, Aryl CH), 2.41 (s, 3H, CH3), 2.40 (s, 6H, CH3), 2.22 (s, 2H, 
Alkyne CH). 11B NMR (128.3 MHz, CDCl3) d –13.3 (s). 13C{1H} NMR (101.6 MHz, 
CDCl3) d 151.6, 143.0, 139.6, 139.0, 130.9, 129.3, 128.6, 125.5, 125.1, 88.1, 77.2, 21.4, 
21.3. FT-IR (ATR, cm–1) 3281, 3031, 2921, 2060, 1606, 1506, 1353, 1281, 1264, 1177.         
UV-Vis (Toluene): lmax = 317 (e = 24 200 M–1 cm–1),  524 nm (e = 14 400 M–1 cm–1). 
ESI-HRMS (+ve mode) calculated for [C26H23BN4]+: 402.2016, found 402.2017, 
difference: +0.3 ppm. 
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Cycloaddition Complex 3.12 
Under N2, N,N,N′,N′′,N′′-Pentamethyldiethylenetriamine 
(PMDETA) (3 µL, 0.02 mmol) and CuI (3 mg, 0.02 mmol) 
were dissolved in dry THF (3 mL) and stirred for 30 min. 
The solution gradually changed from clear to pale yellow. 
Benzyl azide (58 µL, 0.50 mmol) was added dropwise 
followed by complex 3.10 (62 mg, 0.2 mmol). The resulting 
purple solution was diluted with THF (7 mL) and stirred at 
45 oC for 18 h. The solution was then cooled to room 
temperature, gravity filtered and the supernatant 
concentrated in vacuo. The resulting residue was purified by flash chromatography 
(CH2Cl2, silica gel) to afford complex 3.12 as a purple film. Yield = 0.050 g (38%).        
1H NMR (399.8 MHz, CDCl3) d 8.05 (dm, 2H, JHH = 8 Hz, Aryl CH),                              
7.37–7.35 (m, 6H, Aryl CH), 7.31 (d, 2H, JHH = 8 Hz, Aryl CH), 7.26–7.24 (m, 6H, 
Aryl CH and triazole CH), 7.07 (dm, 4H, JHH = 8 Hz, Aryl CH), 6.97–6.94 (m, 4H, Aryl 
CH), 5.35 (s, 4H, Benzyl CH), 2.44 (s, 3H, CH3), 2.32 (s, 6H, CH3). 11B NMR (128.3 
MHz, CDCl3) d –6.0 (s). 13C{1H} NMR (101.6 MHz, CDCl3) d 153.8, 143.2, 139.4, 
139.2, 136.4, 135.6, 130.7, 129.4, 129.2, 129.1, 128.4, 125.7, 125.5, 124.5, 77.2, 52.1, 
21.4, 21.2. FT-IR (ATR, cm-1) 3034, 2926, 2855, 1604, 1505, 1355, 1282, 1262, 1211, 
954, 821. UV-Vis (Toluene): lmax = 295 nm (e = 29 750 M–1 cm–1),  532 nm (e = 13 100 
M–1 cm–1). ESI-HRMS (+ve mode) calculated for [C40H37BN10]+: 668.3296, found 
668.3314, difference: +2.6 ppm. 
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Chapter 4 
 
4.1 Conclusions  
The work included in this thesis describes the synthesis and characterization of the first 
alkynyl-substituted boron formazanate complexes. This work began by synthesizing a 
tri-p-tolyl BF2 formazanate (2.7) from the parent formazan (2.6) by heating overnight 
at 80 oC in a toluene solution containing excess BF3•OEt2 and NEt3 under inert 
atmosphere. The alkynyl-substituted boron formazanate complexes were then 
synthesized using 2.2 equiv. of the corresponding lithiated terminal acetylenes to afford 
the final complexes 2.8–2.10 in 17–35% yields. In each case, formation of these 
complexes was accompanied by a disappearance of the 1:2:1 triplet and appearance of 
a broad singlet in the 11B NMR spectrum. IR spectra confirmed the presence of an 
internal alkyne functionality at roughly 2186 cm–1. X-ray crystallography revealed that 
the parent complex 2.7 was relatively planar, with the boron atom displaced from the 
plane of the formazanate backbone by 0.094 Å, while the boron atom of 2.8 was further 
displaced by 0.713 Å. Significant twisting of the 1,5-aryl substituents with respect to 
the formazanate backbone was also observed in complex 2.8, which existed in a 
‘dragonfly’ conformation. UV-Visible absorption spectra of compounds 2.7–2.10 
revealed strong p®p* transitions in both 317–320 and 519–532 nm regions, with lmax 
values of complexes 2.8–2.10 exhibiting a blue-shift of 11–13 nm relative to the parent 
complex 2.7. None of the alkynyl-substituted complexes exhibited any detectable 
photoluminescence, which was attributed to the non-radiative vibrational and rotational 
decay pathways relating to the 3-phenyl substituent. Compounds 2.7–2.10 were found 
to be redox active and possessed two ligand-centred reversible (or quasi-reversible) 
one-electron reduction waves yielding a radical anion and dianion. One ligand-centred 
reversible (or quasi-reversible) one-electron oxidation was also observed for each 
compound, yielding a radical cation. It was found that 2.8–2.10 were more difficult to 
reduce and easier to oxidize with no fluorine atoms present. 2.10 was found to be the 
easiest to reduce as a result of the electron withdrawing CF3 substituent at the para 
position of the substituted phenylacetylene. 2.9 was found to be the most difficult to 
reduce as a result of the electron donating OMe substituent at the para position of the 
substituted phenylacetylene.  
  
81 
 
Figure 4.1. Formazanate and boron formazanate complexes studied in Chapter 2. 
 
Chapter 3 focused on the incorporation of a redox-active alkynyl-substituted boron 
formazanate complex, and explored the chemical oxidation and reduction of the system. 
Post-synthetic modification of the boron formazanate scaffold was also explored using 
the alkynyl functionality as a handle for CuAAC chemistry. This chapter began by 
synthesizing the neutral ferrocene complex 3.5 using the previously described lithiation 
procedure. Formation of this complex was accompanied by a disappearance of the 1:2:1 
triplet and appearance of a broad singlet in the 11B NMR spectrum. IR spectroscopy 
confirmed the presence of an internal alkyne functionality at 2188 cm–1. X-ray 
crystallography revealed that the boron atom was significantly displaced from the 
backbone of the formazanate backbone by 0.755 Å, moreso than the boron atoms of 
both the parent BF2 complex 2.7 as well as the phenylacetylene complex 2.8. More 
significant twisting of the 1,5-aryl substituents relative to the formazanate backbone 
was also observed in complex 3.5, with dihedral angles of 66.9° and 67.9° compared to 
54.9° and 60.6° of complex 2.8, likely due to the increased steric effect of the ferrocene 
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substituents. Complex 3.5 was found to be redox-active and exhibited two ligand-
centred reversible (or quasi-reversible) one-electron reduction waves yielding a radical 
anion and dianion. One ligand-centred quasi-reversible one-electron oxidation was also 
observed, with a second reversible oxidation event corresponding to the ferrocene 
substituents. Interestingly, this oxidation wave was attributed as a two ´ one-electron 
process. The coincidence or near coincidence of the waves indicated that there is little 
or no communication between the two ferrocene substituents through the boron atom, 
as both ferrocene moieties oxidize at the same (or nearly the same) potential. Based on 
the information obtained from the cyclic voltammograms, appropriate oxidants and 
reductants were selected in order to probe the chemically reduced and oxidized forms 
of the ferrocene complex 3.5. CoCp*2 was selected to reduce the ferrocene complex, 
while tris(4-bromophenyl)ammoniumyl hexachloroantimonate (magic blue) was used 
as the oxidant. In order to provide an accurate basis for comparison, phenylacetylene 
complex 2.8 was also reduced using CoCp2. UV-Vis absorption data revealed that upon 
reduction with CoCp*2, the UV trace of 3.6 closely matched that of the reduced 
phenylacetylene complex as well as previously published reports, providing evidence 
for a singly reduced formazanate backbone. Further supporting the presence of radical 
complex 3.6 was a broad, featureless EPR signal at g = 2.0035. Upon oxidation of the 
neutral ferrocene complex, 3.8 exhibited a red-shift of 40 nm in the p®p* region from 
501 to 541 nm. Furthermore, complex 3.8 did not produce a signal in the EPR spectrum, 
as ferrocenium is generally not detectable above 77 K. 
 
 
 
  
83 
                      
 
Figure 4.2. Ferrocene complexes studied in Chapter 3. 
 
CuAAC chemistry was explored using terminal acetylenes at the boron centre in order 
to further expand the scope of boron formazanate chemistry (Scheme 4.1). As a proof 
of concept, benzyl azide was used as a model reactant for the CuAAC reaction with 
complex 3.10 to afford the cycloaddition product 3.12 in a 38% yield. 1H NMR 
confirmed the disappearance of the terminal acetylene protons at 2.23 ppm and the 
appearance of the diagnostic benzyl protons at 5.36 ppm as well as the proton signal 
corresponding to the triazole rings at 8.07 ppm. IR spectroscopy confirmed formation 
of the cycloaddition product as the terminal acetylene stretch at 2060 cm–1 of complex 
3.10 disappeared. UV-Vis absorption data revealed a slight red shift in the p®p* region 
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from 524 to 532 nm, consistent with other reports for similar cycloaddition complexes 
of BF2 formazanate systems. 
 
 
Scheme 4.1. CuAAC chemistry studied in Chapter 3. 
 
In conclusion, a new family of dyes has been synthesized which exploit chemistry at 
the boron atom of the boron formazanate scaffold. While the impact of electron 
withdrawing and electron donating substituents don’t play a significant role in altering 
the spectroscopic properties of these complexes, it has been demonstrated that new 
functionalities can be introduced. This new functionality provides a broader scope of 
possible reactions that may be explored, and as a result, broaden the scope of possible 
applications for these dyes.  
 
4.2 Future Work 
Taking advantage of chemistry at the boron centre will hopefully allow these molecular 
systems to find more widespread use in applications. For example, using CuAAC 
chemistry in order to append the boron formazanate scaffold to other materials through 
the boron atom instead of through the N-aryl substituents would allow for the 
introduction of functionality at the N-aryl positions that would otherwise not be 
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CuAAC chemistry, it may be possible to use the Knoevenegal condensation in order to 
install conjugated ferrocene units to the N-aryl substituents of the formazanate 
backbone (Scheme 4.2).  
 
 
Scheme 4.2. Proposed Knoevenegal condensation and CuAAC toward the synthesis of 
multifunctional ethynyl-substituted boron formazanate complexes. 
 
The benefit of this molecular system is that the ferrocene units are conjugated to the 
formazanate backbone and will have a greater impact on the electronics of the system 
in contrast with ferrocene units at the boron atom. This will greatly affect the 
spectroscopic properties of the complex upon oxidation (or reduction), while the non-
conjugated portion of the scaffold at the boron atom may be used to tether this scaffold 
to materials, as demonstrated with the cartoon in Scheme 4.2. 
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Appendices 
Appendix A – Supporting Information for Chapter 2 
 
Figure A1.1. 13C{1H} NMR spectrum of 2.7 in CDCl3. 
 
Figure A1.2. 1H NMR spectrum of 2.8 in CDCl3. 
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Figure A1.3. 11B NMR spectrum of 2.8 in CDCl3. 
 
Figure A1.4. 13C{1H} NMR spectrum of 2.8 in CDCl3. 
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Figure A1.5. 1H NMR spectrum of 2.9 in CDCl3. 
 
 
Figure A1.6. 11B NMR spectrum of 2.9 in CDCl3. 
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Figure A1.7. 13C{1H} NMR spectrum of 2.9 in CDCl3. 
 
 
Figure A1.8. 1H NMR spectrum of 2.10 in CDCl3. 
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Figure A1.9. 19F NMR spectrum of 2.10 in CDCl3. 
 
 
Figure A1.10. 11B NMR spectrum of 2.10 in CDCl3. 
 
N
N N
N
B
CF3F3C
-61.0 -61.5 -62.0 -62.5 -63.0 -63.5 -64.0 -64.5
Chemical Shift (ppm)
-6
2.
75
5 0 -5 -10 -15 -20 -25 -30
Chemical Shift (ppm)
-1
2.
03
N
N N
N
B
CF3F3C
  
91 
 
Figure A1.11. 13C{1H} NMR spectrum of 2.10 in CDCl3.  
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Appendix B – Supporting Information for Chapter 3 
 
Figure B1. 1H NMR spectrum of 3.5 in CDCl3. 
 
 
Figure B2. 11B NMR spectrum of 3.5 in CDCl3. 
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Figure B3. 13C{1H} spectrum of 3.5 in CDCl3. 
 
 
 
 
Figure B4. 11B NMR spectrum of 3.9 in CDCl3. 
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Figure B5. 13C{1H} spectrum of 3.9 in CDCl3. 
 
 
 
Figure B6. 11B NMR spectrum of 3.10 in CDCl3. 
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Figure B7. 13C {1H} NMR spectrum of 3.10 in CDCl3. 
 
 
 
Figure B8. 11B NMR spectrum of 3.12 in CDCl3. 
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Figure B9. 13C {1H} NMR spectrum of 3.12 in CDCl3. 
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